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ABSTRACT
Potential Mechanisms Linking Nutrition and Neuroendocrine
Control of Reproduction in the Sheep
Adam B. Dobbins

Nutrition and reproduction are linked in that the nutritional status of an individual
influences its reproductive performance, i.e. an individual in negative energy balance will
have decreased ability to reproduce. The mechanisms in which nutrition influences
reproduction are not understood. My data suggest that reductions in lutenizing hormone
secretion resulting from photoperiod-induced increases in sensitivity to testosterone
negative feedback may be mediated, at least in part, by elevated neuropeptide Y (NPY), a
hypothalamic neuropeptide shown to alter gonadotropin releasing hormone release and
potently affect food intake. The results from my second study support our hypothesis that
the growth hormone mediated hormone, insulin like growth factor-1 (IGF-1) increases
thyroid hormone levels during food deprivation.

Furthermore, results from these

experiments show that food deprivation has a greater impact on males than females and
that the thyroid hormone response to IGF-1 during food deprivation is much greater in
females. Though there are likely many humoral and neuroendocrine factors that must act
together to coordinate the reproductive response to nutrition, our studies with NPY and
IGF-1 have begun to examine some potential mechanisms linking nutrition and
neuroendocrine control of reproduction in the sheep
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CHAPTER 1: REVIEW OF LITERATURE
1) Seasonality in Female and Male Sheep
1.a.) Reproduction
1.a.1.) Reproductive Endocrine Axis
Control of reproductive function in mammals involves endocrine interactions
among the hypothalamus, anterior pituitary, and gonads.

Gonadotropin releasing

hormone (GnRH) is the primary neurohormone regulating reproductive function. GnRH
neurons, derived from the olfactory placode during development, are found spread
throughout the preoptic area (POA) and medial basal hypothalamus (MBH) in sheep (14), as well as in rodents (5). These neurons are not located in any one particular nuclear
region of the forebrain or hypothalamus. Among various species 40-50% of GnRH
neurons are thought to terminate in the median eminence (1;3-8). With regard to the
sheep, the majority of GnRH neurons are found in the medial POA with a significantly
greater number of neurons projecting from here to the median eminence than from other
areas, indicating that the POA likely gives rise to the majority of GnRH that is released
(3). GnRH is released in a pulsatile fashion into hypothalamo-pituitary portal blood
leading to the pulsatile release of luteinizing hormone (LH), and a relatively continuous
release of follicle stimulating hormone (FSH), from the anterior pituitary gland. Both LH
and FSH are involved in regulating production of gametes and hormones in males and
females. The frequency of GnRH pulses, and consequently LH pulses, is the code used
by the nervous system to control testicular/ovarian function (9).

Due to its rapid

breakdown in the peripheral vasculature, GnRH is only measurable in the portal blood,
and is therefore very difficult to assess. Thus, LH is often used as a peripheral marker to
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reflect the activity of a neural oscillator, or pulse generator, that produces episodic
secretions of GnRH. At least in the sheep, each LH pulse is preceded by a GnRH pulse
(10).
Release of GnRH and LH/FSH is impacted greatly by circulating gonadal
steroids. Testosterone is predominantly released by the testes and can be converted into
dihydrotestosterone (DHT) via the enzyme 5-α-reductase, or into estradiol via the
enzyme aromatase. DHT and estradiol feed back at the hypothalamus to decrease GnRH
release and at the pituitary to decrease the response to GnRH. In the female, LH and
FSH stimulate ovarian production of estradiol and progesterone. Progesterone and low
levels of estradiol act to inhibit GnRH release and alter pituitary sensitivity to GnRH.
However, high levels of estradiol cause the pre-ovulatory GnRH and LH surge.
Sensitivity to steroid negative feedback changes throughout the year, so that GnRH and
LH secretion is relatively high during the breeding season and decreased during the nonbreeding season.
1.a.2.) Seasonal changes in GnRH/LH Release
Sheep are seasonal breeders with initiation of reproductive activity occurring
during the shortening days of late summer and fall, and terminating during the
lengthening days of late winter or early spring (11;12).

These seasonal swings in

reproductive activity are due largely to changes in pulsatile patterns of GnRH, and thus
LH, secretion.

The alterations in patterns of GnRH and LH release are due to an

interaction of daylength and steroid negative feedback (13-17). Based on the expression
of estrous cycles, female sheep demonstrate an abrupt change from breeding season to
non-breeding season.

In ewes that have been ovariectomized and implanted with
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estradiol, GnRH and LH secretion exhibit a high frequency pattern of release during the
breeding season, whereas during the nonbreeding season, GnRH and LH secretion is
characterized by a low-frequency pattern of release. Within the breeding season of ewes,
pulses of LH and GnRH are infrequent during the luteal phase of the estrous cycle,
reported at 0-2 pulses over a 6-hour period (18). This is due to the presence of a
progesterone-producing corpus luteum at the site of ovarian rupture. During pregnancy,
high progesterone acts as an inhibitor of LH secretion (19;20), inhibiting estrous cycles
and allowing the individual to maintain the pregnancy. A low level of estradiol is
maintained throughout the luteal phase, which acts to enhance the inhibitory effects of
progesterone; estradiol reduces pulse amplitude, while progesterone reduces pulse
frequency (21). During the follicular phase, GnRH and LH pulse frequency increases
dramatically to 8 pulses per 6 hour period following withdrawal of progesterone during
luteolysis (18). During this period, estradiol is a weak inhibitor of LH release and does
not suppress LH pulse frequency (13), but rather increases pulse frequency (22). During
the anestrous period, however, estradiol is an extremely powerful inhibitor of LH pulse
frequency (23;24) and contributes to decreased pulsatile GnRH and LH release (25),
which drops to a frequency of 1-2 pulses per 12 hour period (18). These changes in
estradiol negative feedback are, in large part, responsible for seasonal variations in LH
release.
Males also show seasonal alterations in fertility, though changes among seasons
are more gradual than in females.

Lincoln (26) reviewed the seasonal changes in

reproduction in males of the Soay breed of sheep. There is a seasonal cycle in the blood
concentrations of FSH with a marked increase from June to September, consistent with
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its role in stimulating spermatogenesis and growth of the testis. The testes are fully
enlarged in October at the beginning of the rut, when most matings occur in the wild. In
other, less seasonal breeds, like Hampshire and Suffolk, no seasonal change in LH is
reported (27;28). Furthermore, seasonal changes do not occur in the same time frame for
males and females. LH concentrations rise earlier in the fall in adult males than in adult
females (29), possibly due to differing sensitivity to estradiol and testosterone between
the two sexes. Nonetheless, comparable circannual changes in gonadal feedback exist in
the male as in the female. Entry into the breeding season is governed by an increase in
pulsatile LH secretion as a result of a reduced response to testosterone negative feedback
in rams. Testosterone is converted into estradiol via aromatization and into DHT via 5-αreduction and the relative contribution of each of these metabolites for controlling GnRH
release is unclear. Estradiol is inhibitory to LH at physiological concentrations in steers
(30) as well as sheep (31;32) and blockade of the conversion of testosterone to estradiol
increases LH secretion in male sheep (33). Castrated rams given DHT demonstrated a
lack of responsiveness of LH release to exogenous GnRH when compared to untreated
animals (34).

DHT appears to be of physiological importance since blocking 5-α-

reductase activity significantly blunts the ability of testosterone to inhibit pulsatile LH
release (35), possibly acting at the pituitary since there is a large amount of 5-α-reductase
activity (36) and a high number of DHT binding sites (37) in male and female calf
pituitary glands.
Photoperiod provides input to control the timing of changes in steroid sensitivity.
A switch from long to short days results in a progressive decline in LH concentrations,
while a switch back to long days caused the opposite response in LH (17). These
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observations lead to the conclusion that the inhibitory photoperiod of anestrous enables
estradiol and/or DHT to act within the brain to depress LH pulse frequency. This action
is significantly diminished by the inductive photoperiods of the breeding season (38).
1.a.3.) Mechanisms of Steroid Negative Feedback
The neural mechanisms that mediate steroid negative feedback on gonadotropin
release are not fully understood. In male sheep, testosterone, or its metabolites like DHT
and estradiol, acts primarily, although not exclusively, on the brain to suppress GnRH
pulse frequency. Specifically, castration leads to an increase in GnRH pulse frequency,
yet LH pulse frequency does not increase significantly (39), whereas testosterone
replacement reduces GnRH pulse frequency, yet has a marginal effect on pituitary
response to exogenous GnRH (40). Evaluation of pituitary responsiveness across various
times of the year leads to the conclusion that testosterone does act directly on the
pituitary to modulate the response to GnRH, yet since LH pulses still mirror GnRH
pulses, it is still maintained that shifts in LH pulse frequency reflect parallel changes in
GnRH pulse frequency rather than profound changes in pituitary responsiveness to GnRH
(27). The neural sensitivity to the negative feedback action of testosterone as well as
circulating concentrations of testosterone vary greatly with stage of the annual
reproductive cycle (27). Thus it is likely that the relative effect of testosterone on the
pituitary versus brain also varies with stage of the annual reproductive cycle (41).
Cells containing estrogen receptors (ER) in the brain of the ewe are distributed
throughout many areas of the brain and hypothalamus, including the medial POA,
anterior hypothalamic area, ventromedial septum, bed nucleus of the stria terminals
(BNST), ventral medial nucleus (VMN), and arcuate nucleus (Arc) (42-44). Similar to
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guinea pigs, but not to rats or monkeys (45), ER-immunoreactive cells have been
detected in the supraoptic nucleus (SON) of ewes within its dorsomedial aspect (43).
Only very few ER-immunoreactive cells are found in the paraventricular nucleus (PVN).
In ewes, the highest density of ER-immunoreactive cells is found in the Arc (42), and ER
have been reported in the anterior pituitary gland (46-48). Blache et al. (42) used brain
sections from both ovariectomized and estradiol-replaced ovariectomized ewes and found
no effect of estradiol on ER-positive cell density in the POA, VMN, or Arc. However,
progesterone administration did result in the detection of greater numbers of ERimmunopositive cells in the VMN of ovariectomized ewes (42). In the VMN of male
sheep there are substantially fewer ERα containing cells and less ERα mRNA per cell
than ewes (49). In addition, a similar finding for the mPOA and VMN has been reported
for rats (50). The more recently discovered estrogen receptor-β (ERβ) is present in the
Arc, VMN, POA, SON, and PVN within the hypothalamus (49;51), though its role in
mediating various aspects of the GnRH response to estradiol remains unclear (52).
In general, the overall distribution of androgen receptor (AR)-containing cells in
males is very similar to that of ER in ewes, with the largest numbers of ARimmunopositive cells found in the medial POA, VMN, and Arc (45). In the VMN, ARpositive cells are located more medially in the dorsomedial division whereas estrogen
receptors are not found in this particular subregion (45). AR-positive cells are detected
throughout the Arc, but at a much lower density compared to ER-containing cells in ewes
(45).

A very similar distribution has been shown for AR-containing cells in rat

hypothalami (53).
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GnRH neurons in female and male rats do not possess ERα (54;55). Studies with
ovariectomized ewes have similarly demonstrated that GnRH neurons throughout the
hypothalamus do not display ER immunoreactivity (43;56). Likewise, GnRH neurons of
rats do not possess AR (57). A consistent observation from these double-labeling studies
is that GnRH neurons are usually surrounded by ERα and AR-immunopositive cells
(45;55;56).

Based on these studies, it seems likely therefore that steroid-receptive

interneuron populations mediate the influences of estradiol and androgens (i.e.
testosterone and DHT) upon GnRH neurons.
In the absence of estradiol in the female sheep (58), or in the absence of
testosterone in the male sheep (17;59), a relatively small photoperiod-induced decline in
LH pulse frequency and an increase in pulse amplitude still occurs when animals are
exposed to natural or artificial long-day photoperiods.

Larger steroid-independent

suppression of circulating gonadotropin concentrations during inhibitory photoperiods are
apparent in other species such as red deer hinds (60), and snowshoe hare bucks and does
(61).

These steroid-independent rhythms are often considered to be the result of

variations in an underlying direct photoperiodic drive to gonadotropic output (58;61),
which is further modified by steroid negative feedback (38). Lincoln (17) reported
similar results for rams under controlled, artificial lighting. Other hormones, such as
thyroid hormones (62), may play a role in these steroid independent changes in LH.
1.b) Food Intake
1.b.1.) Influence of Photoperiod
Many species living in temperate and cold climates express profound seasonal
changes in voluntary food intake (VFI) and body weight. There is evidence that long-
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term cycles in VFI, growth, and pituitary hormone secretion persist in sheep living under
constant photoperiod and environmental conditions (63). This supports the view that the
seasonal cycle in VFI is generated endogenously. Under natural conditions, the response
to the annual cycle in day length acts to entrain the period of endogenous rhythm to a
period of exactly 12 months in order to time the anabolic growth phase to summer when
food is most abundant and the catabolic anorexic phase to winter when food is scarce
(64;65). Artificial conversion from short days to long days provokes an increase in VFI
and exposure to alternating 3-6 month periods of long and short days drives the cycle in
VFI and body weight (65). These photoperiod-induced changes are controlled, in large
part, by mechanisms residing within the hypothalamus.
Many neuropeptides that have been isolated in the hypothalamus are capable of
influencing VFI. Orexigenic peptides, such as neuropeptide Y (NPY) and agouti-related
peptide (AgRP), are up-regulated under long days in sheep (65) and hamsters (66) in
association with an increase in appetite in males. An increase in arcuate NPY has been
reported in females on a long day photoperiod (64). Barker-Gibb et al. (67) reported that
seasonal changes in NPY in the ewe are not dependent on steroids.

In the male,

expression of the proopiomelanocortin (POMC) gene is reduced under long days in
testosterone-implanted castrate sheep (68) and hamsters (66), while being increased
during long days in ovariectomized ewes (64). One potential reason for these differences
could be due to gender. Alternatively, NPY and POMC may be regulated differently in
the context of season and steroid milieu. Orexigenic melanin concentrating hormone
(MCH) is reduced under long days in males, but changes in expression may be linked to
its role in regulating the reproductive axis more so than regulating VFI (65). It is
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important to note that POMC serves as a precursor to both anorexic α-melanocytestimulating hormone (αMSH) and orexigenic β-endorphin so its role in controlling food
intake is more complicated (69).
1.b.2.) Role of Steroids
Gonadal hormones are involved in the regulating food intake in rats (70;71),
hamsters (72), and mice (73). Androgens generally act as anabolic agents that increase
food intake and lean mass, whereas estrogens are catabolic and decrease food intake and
body weight. Male rats that are orchiectomized at birth exhibit significant decreases in
rate of body weight gain with a slight or no decrease in daily food intake and testosterone
administration reverses the effect on body weight (70;73-82).

Orchiectomy has no

detectable effects on the quantity of food ingested in adult rats until after about 4 weeks
of age, by which time lean body mass has also decreased (83). Low dose androgen
administration increases food intake in rats, whereas higher doses decrease food intake
(83). Treatment with androsta-1,4,6-triene-3,17-dione, an aromatase inhibiter, increased
food intake and weight gain when administered with high doses of testosterone (84).
This supports the idea that dose dependent effects of testosterone result from the
aromatization to estrogens when testosterone is given in high doses.
In the female, estradiol significantly influences energy balance by reducing food
intake. Ovariectomy produces an immediate increase in feeding in rats and mice, and
estradiol treatment is sufficient to normalize both feeding and body weight (85-88). In
postmenopausal women, there is an increase in total percent body fat.

Hormone

replacement attenuates these fat gains (89). During estrous, ovariectomy eliminates an
estrous-induced decrease in food intake (90). Several studies have reported an inhibitory
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effect of estradiol on NPY mRNA or peptide levels in female rats (91-94). Decreasing
NPY input could be one mechanism by which estradiol helps to decrease food intake.
NPY levels are higher in males than in females. Sexually dimorphic NPY levels
may, at least in part, be due to the metabolism of testosterone to dihydrotestosterone
(DHT). While the influence of DHT on NPY has not been directly assessed, like
testosterone, DHT prevents cold-induced loss of body weight (95), increases body mass
(76), and increases food intake (70;96).

This raises the possibility that DHT may

mediate, at least in part, metabolic responses involving NPY that are influenced by
testosterone. Indirect evidence also indicates that in human subjects some of the effects
of gonadal steroids on food intake and body weight may be mediated to some extent by
influencing serum leptin levels and hypothalamic leptin receptor gene expression (97).

2) Influence of Nutrition on Reproduction
Producers have long known the importance of proper nutrition for increasing
conception rates and decreasing postpartum intervals.

The mechanisms whereby

nutrition influences reproduction are not completely understood.

In the following

section, the influences of nutrition on three hallmarks of reproduction (puberty,
postpartum return to breeding, and expression of estrous cycles) will be discussed, along
with potential mechanisms that link nutrition and GnRH/LH secretion.
2.a.) Nutritional Influences on Puberty, Postpartum Interval, and Estrous Cycle
Expression
Puberty is the time in life when mature gametes are first produced and individuals
become capable of reproducing.

This is due to an increase in activity from the
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reproductive endocrine axis, i.e. an increase in GnRH and LH release. In the sheep this is
the result of a decreased responsiveness of the hypothalamus to estradiol negative
feedback. As measured by an increase in LH, puberty occurs earlier in the male lamb
than in the ovariectomized female lamb. In the immature female, LH pulse frequency is
low and increases typically at 25-35 weeks in spring born lambs (98).

LH pulse

frequency is also initially low in the male, but increases to near pubertal levels by 9-11
weeks (99). This sex difference is due to an earlier decrease in response to steroid
negative feedback in the males (100). Foster et al. (101) failed to find an increase in the
frequency of pulsatile LH secretion in ovariectomized lambs at the time when intact
lambs began their first reproductive cycles suggesting that steroid-independent
mechanisms are likely not overly important. They also ruled out a major influence of
photoperiod in ovariectomized lambs as LH pulse frequency was not influenced by a
photoperiod treatment known to delay puberty in gonad-intact sheep.

However,

insufficient nutrition can delay the peripubertal rise in pulsatile LH secretion that
normally occurs during the stimulatory daylengths of autumn (102).

Still, photoperiod

may play a modulatory role in the onset of puberty. In males, a pre-pubertal increase in
gonadotropins drives increasing testosterone and spermatogenesis to achieve a level of
fertility approximating that of the adult male during the nonbreeding season (103). Once
testicular function approaches a level similar to that of the seasonally suppressed adult
male, subsequent sexual maturation to reach full fertility is more photoperiod-dependent
(104).
In other species, a change in hypothalamic sensitivity to estradiol negative
feedback does not seem to be a component of puberty onset. Ojeda et al. (105) has

11

reviewed the control of puberty in the female rat. In this model the CNS appears to play
a pivotal role. In the time leading up to puberty, there is a centrally driven, gonadalindependent diurnal change in pulsatile LH release.

Basal release of LH and the

magnitude of LH secretory episodes increase markedly in the afternoon. These changes
stimulate the ovary to produce more estradiol which then evokes minisurges of LH
secretion that in turn further stimulate ovarian development and steroidogenesis. The
increase in ovarian steroids, especially estradiol, helps lead to the preovulatory discharge
of GnRH which directly promotes the first surge of gonadotropins and ovulation.
As with sheep, GnRH neurons in primates appear to be functionally mature well
before the onset of puberty in primates (106;107). In fact, following gonadectomy at 1-2
weeks of age, there is up to 10 weeks of elevated mean LH levels observed in both the
male and female monkey, though the increase is more dramatic in the male (108). The
postnatal increase in LH release ends due to central inhibition rather than due to steroid
negative feedback (109;110). Richter and Terasawa (111) reviewed the mechanisms that
are responsible for maintaining gonadotropins at a low level before puberty in the rhesus
monkey, and how these inhibitory mechanisms are diminished at puberty. Gammaaminobutyric acid (GABA), an inhibitory neurotransmitter, along with possible
involvement from additional factors such as NPY, are involved in inhibiting GnRH
release from the hypothalamus. At the onset of puberty in the rhesus monkey there is a
postulated decrease in inhibitory GABA input and an increase in levels of the excitatory
neurotransmitter glutamate, which allows for an increase in LH pulse frequency and the
initiation of estrous. NPY and its role in puberty in primates appears to be sex specific.
In the female rhesus monkey there is an increase in NPY mRNA along with the increase

12

in GnRH, indicating NPY may be stimulatory to GnRH (111). In the male there is a
decrease in NPY mRNA along with an increase in GnRH mRNA suggesting that NPY is
inhibiting GnRH (112).
Regardless of the strategy whereby puberty is attained, onset of puberty is delayed
in all species whenever a female is in negative energy balance (113). Furthermore, the
onset of fertility is also more closely associated with body size and food intake than with
chronological age in females whose growth has been retarded by food restriction (114).
Foster and Olster (102) demonstrated that ewe lambs fed to maintain their weaning
weights were anovulatory at a time when growing lambs became pubertal. McShane and
Keisler (115) demonstrated that hourly injections of LH in underfed lambs induced
follicular growth, LH surges of normal amplitude, and ovulation, indicating that the
hypothalamus is likely involved in decreased reproductive function during times of
reduced nutrition. Indeed, GnRH secretion is inhibited in undernourished lambs (116).
These studies suggest that undernutrition acts to inhibit the increase in GnRH secretion
that is required for puberty to occur. LH pulses and LH surges have been induced in
peripubertal female lambs by administration of GnRH (117), showing that the pituitary
and the ovary are not limiting in pubertal develment. GnRH neurons also seem mature
prior to puberty as evidenced by stimulation of LH release using N-methyl-D-aspartate, a
glutamate analog that triggers GnRH release (117). Refeeding is known to increase
circulating levels of gonadotropins and trigger onset of puberty and expression of estrous
cycles in growth-restricted animals, and exogenous administration of GnRH pulses to
growth-restricted prepubertal rats will induce estrous cycles (118).
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Like puberty, the duration of the postpartum interval, or the time period following
parturition when reproduction is inhibited, is also influenced by nutrition. Postpartum
anestrous is a transition period during which the functional hypothalamic-pituitaryovarian-uterine axis recovers from the previous pregnancy. Time is necessary for uterine
involution to begin, for anterior pituitary LH stores to be replenished, and for waves of
ovarian follicular growth to resume (119). During pregnancy, high circulating estradiol
concentrations inhibit the pulsatile release of GnRH from the hypothalamus.

The

dramatic fall in circulating estradiol concentrations at the time of parturition leads to an
immediate postpartum increase in FSH secretion, which initiates a wave of ovarian
follicular growth within two weeks postpartum in cattle (120) and in sheep (121).
However, follicle maturation and ovulation do not occur unless there is a concomitant
increase in LH pulsatility.
Duration of postpartum anestrous is affected by four major factors: suckling, age,
season, and nutrition (119). Suckling increases the duration of postpartum anestrous and
old or first pregnancy animals often rebreed more slowly. Restriction of dietary energy
late in the prepartum period or early in the postpartum period reduces the number of
animals returning to estrus within a well-defined breeding season. These effects are
apparently attributed to a failure to develop preovulatory ovarian follicles (122). Most
studies examining the postpartum interval have been conducted in cattle. Increasing
energy intake after parturition in thin heifers shortened the postpartum interval (123) and
increased circulating LH concentrations (124). Body condition score at parturition is
positively correlated with follicular development early post partum (125) and pituitary
LH content at 30 days postpartum (126).
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Most ewes give birth at the end of their natural breeding season when photoperiod
is inhibitory to the reproductive axis, making the postpartum period less of a concern in
this species. Nonetheless, a limited body of literature exists concerning postpartum
intervals in sheep. Autumn lambing ewes maintain the opportunity to re-breed during the
fall breeding season. Economically this could be beneficial if a second lamb crop can be
produced in one year, or if the producer has a high priced niche market during the holiday
season.

Mandiki et al. (121) have shown November lambing ewes have a shorter

postpartum interval than July lambing ewes.

Lishman et al. (127) did report that

restricting food intake for 84 days postpartum in ewes that lambed in the autumn reduced
the percentage of ewes returning to estrous. Since dietary energy restriction impairs
pulsatile LH secretion in ovariectomized ewes, it seems reasonable to suggest that energy
restriction would delay or prevent postpartum re-breeding of ewes via alterations in
GnRH/LH release.
Similar to puberty and postpartum return to breeding, inadequate nutrtion also
inhibits the expression of estrous cycles. For example, severely food deprived rats have
lower pituitary, ovarian, and uterine weights (128). Restricted feeding for a prolonged
period affects ovulation rate, timing of the estrous cycle, and ability to reproduce in
rodents (128;129). Tropp and Markus (130) have shown that in Fischer 344 and Brown
Norway rats moderate food restriction (to produce a 15% drop in body weight) can cause
cessation of estrous cycles as early as day one following the onset of food deprivation.
Ad libitum feeding restored estrous cycles in these animals within 2-4 days. In this
study, Sprague-Dawley and Long-Evans rats were more resistant to the effects of mild

15

food restriction than Fischer 344 and Brown Norway rats, indicating that, in rodents,
strain-dependent differences in response to food restriction exist.
Restricted feeding and acute fasting in heifers inhibit cyclic ovarian function and
expression of estrous, and prolonged restriction of dietary energy results in cessation of
estrous cycles in cattle (131;132). Failure to ovulate occurred 32 weeks after initiation of
food restriction to cause a 1% loss of body weight per week (22% average weight loss
over treatment period was actually achieved) (133). Anovulation was likely due to the
observed significant drop in LH and FSH levels. In addition, circulating IGF-1, insulin
and glucose levels were reduced in restricted animals. The potential role of these factors
in mediating the influences of nutrition on reproduction will be discussed later.
Adult ewes maintained on low planes of nutrition also exhibit reduced ovulation
rates (134), a response attributed to reduced ovarian follicular development (135) rather
than to alteration of the pre-ovulatory surge of LH. Effects on follicular development
could result from disruption of pulsatile LH release, and indeed ovariectomized ewes
maintained on a low energy diet exhibit fewer LH pulses and lower mean LH
concentrations in serum (136).
Flushing, or increasing energy intake at least one estrous cycle prior to breeding,
in ewes with low body condition is one way of increasing conception rates and the
number of offspring conceived (134). Ovulation rate in the ewe is influenced by both
body condition at mating and the pre-mating level of nutrition (137;138). These two
phenomena are clearly related since long-term changes in pre-mating level of nutrition
will change the body condition of the ewe at mating (134). The number of eggs ovulated,
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and ultimately the number of lambs born, can be increased in underconditioned ewes by
flushing (139).
2.b.) Site of Influence
As discussed above, although GnRH release is inhibited during undernutrition,
GnRH neurons themselves appear to be functionally normal during undernutrition. The
finding that pulsatile LH secretion can be suppressed in gonadectomized animals
suggests that food restriction can act independently of steroids to suppress GnRH release.
However, evidence exists to suggest that food restriction enhances the ability of estradiol
to inhibit pulsatile LH secretion. The systems underlying this response are unknown.

A

number of neural systems have been shown to express ERα and/or AR and also influence
GnRH release. Such potential mediatiors of steroid action on GnRH release include
galanin (140;141), classical neurotransmitters such as serotonin (142), excitatory (143)
and inhibitory amino acids (144), and local growth factors (145). Some of these neural
mediators of steroid feedback are listed in Table 1 at the end of chapter, along with their
action on GnRH and LH secretion.
NPY is one particularly attractive candidate that may be involved in mediating
steroid negative feedback on GnRH release during undernutrition. NPY, steroid negative
feedback and GnRH release during inadequate food intake could be linked for the
following reasons: NPY alters GnRH and LH release (67;146-148), NPY-containing
neurons synapse directly onto GnRH neurons (149), NPY neurons coexpress ERα (150),
and NPY levels are markedly influenced by nutrition (151). This neurotransmitter will be
discussed in greater detail later in this section.
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2.c.) Male-Female Differences
There are several differences between males and females in the way they respond
to changes in nutrition. Hoyenga and Hoyenga (152) have proposed that due to gender
specific evolutionary selection pressures, female mammals have evolved a greater
capacity to conserve energy than males. Accordingly, food restriction has been reported
to have a greater and more permanent effect on physical growth in males than females
(152). In rats subjected to complete starvation for six days, body mass loss was similar
following starvation, but males lost a greater percentage (16%) of their body mass as
protein than did females (8%). The ratio of lipid to protein lost (g) was 1.16 for males
versus 3.26 for females (153). Taken together these data suggest that females are more
adept at conserving energy during periods of low fuel availability. Differences are also
observed when animals have access to excess calories. Hileman et al. (154) show that
male mice fed a high fat diet gained weight much more rapidly than did female mice,
with increased weight gain being evident by 4 weeks in males. Females, however, did
not show appreciable additional weight gain until week 8, and this was largely due to an
increased response of one female to the high fat diet. Females appeared to be more able
to compensate by decreasing intake, either in total grams of food ingested or kilocalories
eaten, than were the males on a high fat diet.
Several factors that are involved in regulating body weight show sexual
dimorphism. There is a clear effect of sex and season on the satiety functions of leptin in
sheep. During the shortening days of fall, leptin was ineffective as a satiety agent in
either sex. During the lengthening days of spring, however leptin was able to suppress
appetite to a greater degree in female than in male sheep (69). There is also a gender
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difference in the development of leptin resistance in mice following exposure to a highfat diet. Males placed on a high-fat diet for 5 weeks did not lose body fat in response to
physiological doses of leptin infused peripherally. In contrast, female mice on the same
treatment, as well as males and females fed the high-fat diet for 15 weeks, lost body fat
during the leptin infusions (155). There are conflicting data concerning leptin in males
and females. In rats and mice, leptin levels have been reported to be higher in either
males (156) or females (97;156;157). In humans, females consistently have higher leptin
levels than males (158). There is less of a decrease in leptin due to starvation in females
compared to males (157), though the mechanisms underlying these sex-related
differences remain unclear.
In response to fasting, there is a greater reduction in total T4 in females than in
males, though both sexes showed a decrease in T4 following starvation (159).

A

reduction in T4 is consistent with previous studies in both males (160) and females (161)
although direct comparisons between sexes were not performed. Corticosterone levels
following fasting increased to a greater extent for females than for males (159), possibly
due to a more robust metabolic response to food deprivation in females. It is also
possible that starvation may be more stressful for females. Sex-related differences in the
response to stress have been reported (162), and Born et al. (163) have proposed that, at
least in humans, young females are more sensitive to corticosterone releasing hormone
(CRH) since higher CRH levels were required to elicit the same corticosterone levels in
young males.

The magnitude of neuroendocrine and metabolic responses to

hypoglycemia is reduced in women compared with men (164;165). These data suggest
that females are less insulin sensitive compared to males, at least under hypoglycemic

19

conditions (165). Circulating IGF-1 concentrations were greater in prepubertal male
sheep than prepubertal female sheep (166;167). Accordingly, greater concentrations of
plasma IGF-1 were found in rams than in ewes around the time of puberty (168), but in
this study sex differences before puberty were not detected.
As mentioned earlier, a sex-dependent difference in the timing of puberty exists
for male and female sheep.

These differences arise because the time course of

gametogenesis and the metabolic investments in reproduction can be quite different in the
two sexes. It takes longer for gametogenesis in males so there must be a time difference
in order for them to be prepared to breed at the same time as the females. As mentioned
earlier, the pubertal increase in LH secretion occurs in male sheep at about 10 weeks and
in female sheep at about 30 weeks of age (169).

This is due to a sex-dependent

difference in responsiveness to inhibition of GnRH secretion by estradiol. Thus, the
period of high responsiveness to estradiol lasts three-fold longer in prepubertal female
sheep than in male sheep (100). The stimulatory feedback mechanism by which estradiol
induces LH surges is also sexually differentiated in sheep (32). In castrated adult sheep,
treatment with high physiological levels of estradiol promptly suppresses tonic LH
secretion in both sexes. However, within 24 hours this negative feedback response is
followed by an LH surge only in females. With regard to seasonal fertility, reproductive
activity is highly seasonal in the female sheep, and tends to be all or none, whereas the
male remains fertile year-round with relatively less seasonal variation in fecundity and
libido (26). Seasonal changes in LH levels do not occur in the same time frame between
males and females as LH concentrations rise earlier in the fall in adult males than in adult

20

females (29), possibly due to differing influences of estradiol and testosterone between
the two sexes.
2.d.) Theories concerning the link between nutrition and reproduction
The reduction in GnRH and LH pulse frequency observed during dietary energy
restriction is dramatic and probably represents the most important means by which
undernutrition impairs reproductive activity.

Early observations in humans that

menarche occurred at a critical level of body fatness led to the hypothesis that body
fatness somehow regulates reproductive activity (170). The critical body fat hypothesis
is supported by data from a wide variety of species and physiological situations. Body
weight is related to mean LH levels and the continued expression of estrous cycles in
cattle (132;171) and is correlated with the postpartum interval (172). Because weight
loss in adult animals is primarily due to a loss of fat, the reduction in LH pulse frequency
associated with prolonged dietary energy restriction or decrease in bodyweight/body
condition scores is associated with a reduction in body fatness (132;136). The extent of
an animal’s energy reserve can also influence the time required for undernutrition to alter
the reproductive axis. A two-day fast blocks estrous cycles in lean, but not fat hamsters
(173).

Thus, it seems plausible that metabolic changes resulting from changes in

nutrition and paralleling changes in body adiposity somehow regulate pulsatile LH
release.
Body fat could exert its effects on reproduction through an alteration in steroid
metabolism (174). Changes in body weight and body fat are associated with changes in
estradiol metabolism (174) and a high level of androgen aromatization into estradiol
occurs in adipose tissue (175).

However, impaired tonic LH secretion caused by
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undernutrition is observed in gonadectomized lambs (102), rats (176), and the rhesus
monkey (177). If body fatness does alter the activity of the reproductive axis, it is
probably through steroid-independent or steroid-modulated mechanisms.
Arguing against a direct role for body fat as a trigger for reproduction are a
number of experiments having demonstrated that body fat lacks a direct physiological or
biological relationship to the onset of estrous cycles (178). In intensively trained female
athletes, menarche is not achieved for months following the attainment of a body weight
and composition expected to produce menarche in girls not subjected to such intense
training (179). In addition, in some studies puberty and body adiposity can be dissociated
(180-183). In addition, when metabolic fuels are supplied, the level of body fat is
irrelevant to the maintenance of estrous cycles (173). Instead, the amount of energy
stored in adipose tissue could be an important component of overall energy balance, and
body fat is probably a marker for the availability of energy for reproductive activity.
The central nervous system still must have some way of detecting changes in the
state of an individual’s energy balance in order to effect changes in GnRH/LH secretion.
Some signal(s) must exist to trigger central changes in response to the body’s energy
state. Blood-borne signals such as metabolites, metabolic fuels, or hormones may serve
as a signal to the brain indicating the current energy state of the organism. This signal
must have the following characteristics: 1) must be secreted in proportion to body energy
status, 2) must have access to the brain, and 3) must effect a predictable response. The
following section will examine some possible metabolic and humoral cues that may serve
as signals to the central nervous system.
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3) Potential Metabolic Signals linking Reproduction and Nutrition
3.a.) Insulin-like growth factor 1 (IGF-1)
Growth is regulated by a number of factors, including environmental signals,
health, nutrition, and the genetic potential for growth of an individual. The IGF’s are
endocrine signals that are critical for normal growth. IGF-1 and IGF-II were first isolated
in large-scale purification from a human plasma fraction by Rinderknecht and Humbel
(184). They are single chain polypeptides with structural homology to proinsulin. They
regulate proliferation and differentiation of a multitude of cell types and are capable of
exerting insulin-like metabolic effects. Traditionally, IGF-II is considered to act in this
manner pre-natally and IGF-1 to act in young and adult animals. They are produced by
most tissues of the body (185-187), are abundant in the circulation, and act in autocrine,
paracrine, and endocrine fashions (188). IGF-1 activity is regulated in part by association
with binding proteins. IGF-1 and IGF-binding proteins (IGFBPs) are present in the
anterior pituitary gland and hypothalamus (189), as well as serum and liver in ruminants
(190).
IGF-1 is part of the growth hormone (GH) axis, where GH-Releasing Hormone
and Somatostatin are released from the hypothalamus to stimulate and inhibit,
respectively, the secretion of GH from the pituitary gland. IGF-1 production by the liver
is stimulated by pituitary GH (191) and accounts for about 75% of circulating IGF-1
levels (192). Circulating IGF-1 feeds back directly on the anterior pituitary to inhibit the
synthesis and release of GH (185;193-195).
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3.a.1.) IGF-1 and Growth/Nutrition
IGF-II is classically thought of as the primary IGF involved in prenatal
development. IGF-II is expressed more widely in the embryo (196) and is required for
normal embryological development, as IGF-II null mice are 60% smaller than normal
littermates (197;198). However, IGF-1 is also essential for embryological development.
IGF-1 knockout mice were not only 60% smaller than littermates, but displayed severe
muscle dystrophy and a high percentage died at birth (199).
Postnatal growth is dependent on normal pulsatile secretion of GH from pituitary
somatotrophs. This is particularly important for the accelerated growth seen during the
peri-pubertal period. Loss of GH secretion can have important deleterious effects in the
maturing organism. GH deficiency results in growth retardation as pituitary-deficient rats
did not gain weight or grow in length unless administered GH or IGF-1 (200). In
addition to increasing bone length and width and skeletal muscle growth, GH and IGF-1
increase kidney, spleen, and thymus weight, and decrease the weight of epididymal fat
pads (201). Despite having markedly increased circulating GH levels, IGF-1 knockout
mice are small, suggesting that the major effects of GH on growth are dependent on IGF1 expression (192). In a study of GH deficient rats, administration of human GH (hGH)
had no significant effect on relative weights of various organs, whereas a high dose of
hIGF-1 had significant stimulatory effects on the kidney and spleen. Both hGH and
hIGF-1 increased the relative weight of the adrenals, but this was only significant for
hIGF-1 treatment (200).
IGF-1 levels are affected by a lack of dietary energy. Food restriction decreases
serum IGF-1 in rodents (202;203), lactating rats (204), ruminants (205), and humans
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(206;207). Furthermore decreased IGF-1 due to food restriction cannot be reversed by
administration of GH (206). In guinea pigs, IGF-1 was significantly reduced in animals
fed 70% of their normal diet for a period of 3-4 days (203). There was a significant IGF1 response to a 24-hr food restriction at 5 weeks of age in mouse lines that were bred both
for lean body mass increase and fat body mass increase (202). Across other species there
is a delay in IFG-1 response to nutrition deficiency. In adult canines it takes 4 days of
fasting before a decrease in IGF-1 is seen (208), and in adult humans there is also a
decrease in IGF-1 over 9 days of food restriction (206).

The decline in IGF-1

concentrations during fasting is due to a decrease in binding of GH to its hepatic receptor,
even though GH levels remain constant or even increase.

These changes are

accompanied by decreases in hepatic IGF-1 and GH receptor mRNA abundance
(209;210). Thus, during food restriction, the ability of GH to induce IGF-1 is reduced.
3.a.2. IGF-1 and Reproduction
Several studies have implicated IGF-1 as a putative metabolic signal linking
nutritional state with reproduction.

The ability of IGF-1 to act directly on the

hypothalamus of immature animals to affect GnRH neuronal activity was first shown in
vitro when IGF-1 stimulated GnRH release from the rat median eminence (211). Other
in vitro experiments have shown that IGF-1 can have an inhibitory effect on the release
of GnRH (212). These researchers applied IGF-1 to a larger hypothalamic area, and
postulate that differences may be due to site-specific differences in IGF-1 inputs
controlling GnRH secretion. In vivo, female rats exhibited an increase in LH release
following i.c.v. administration of IGF-1, apparently due to an increase in GnRH as the
response was blocked by administration of antibodies to GnRH (213).
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IGF-1 may play a role in puberty onset and appears to act at all levels of the HPG
axis to influence reproduction.

IGF-1 crosses the blood-brain barrier by a specific

transport system and is present in the CSF (214). IGF-1 receptors are widely distributed
in the hypothalamus and even more abundantly expressed in the pituitary (215). Locally
produced IGF-1 augments ovarian granulosa (216) and testicular cells (217) production
of steroid hormones. Ovarian IGF-1 has been implicated as a hormone influencing the
action of both FSH and LH and almost all known actions of FSH are amplified by IGF-1
(216). Peripherally administered IGF-1 has been shown to stimulate LH secretion in
sheep in a dose dependent manner. It seems that IGF-1 is intrinsically stimulatory to LH
at low doses, but is inhibitory at higher doses due to hypoglycemia induced by IGF-1
acting at the insulin receptor (218). It seems that estradiol may be important for IGF-1 to
inhibit LH secretion. Higher IGF-1 doses (100 and 150 µg/kg), did not affect LH
secretion in ovariectomized ewes but LH levels decreased by 16-22% in the presence of
estradiol (218). In vitro studies have shown that IGF-1 is capable of stimulating LH
release from cultured ovine pituitary cells independent of GnRH (215). Circulating
levels of IGF-1 are elevated at puberty in rodents (213;219), primates (220), and
ruminants (221). The onset of puberty is delayed in heifers immunized against GRF (to
decrease serum GH and serum IGF-1 concentrations) at three and six months of age
(188;222).
Estradiol has been shown to regulate IGF-1 gene expression in several tissues
including the uterus (223).

In the ovariectomized rat, estradiol increases IGF-1 mRNA

and IGFBP-2 mRNA throughout the anterior pituitary while IGF-1 receptor mRNA
expression is unchanged (224). However, castration enhances, rather than abolishes the
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IGF-1 surge which occurs at puberty (219). This could be due to different actions of
estradiol vs. testosterone. Collectively, available evidence points to IGF-1 acting as a
hormonal factor that can mediate the effects of inadequate nutrition on gonadotropin
secretion.
3.b.) Insulin
Insulin is released from pancreatic β-cells in response to increased glucose levels
and is therefore closely associated with nutritional status in an acute sense. Peripheral
concentrations of insulin are directly proportional to the level of food intake (225) and
body adiposity (226) and thus may serve as a long-term indicator of nutritional state.
Insulin enters the CSF from plasma via a receptor-mediated transport system (227). In a
variety of species the brain, and in particular the hypothalamus, contains both insulin and
insulin receptors (228). Van Houten et al. (229) showed that insulin receptors are present
in the arcuate nucleus and median eminence in rats. The anatomical location of mRNA
for insulin receptor in the hypothalamus provides evidence that insulin acts directly to
influence hypothalamic function.

Indeed, it has long been known that insulin acts

centrally to decrease food intake (230;231). Schechter et al. (232) have shown mRNA
encoding insulin in the brain of rabbits, indicating a potential role of locally produced
insulin.
Insulin also has actions on the reproductive axis.

Increases in insulin

concentrations in both the peripheral circulation and CSF are associated with increases in
gonadotropin secretion (233). In vitro, insulin can stimulate the release of GnRH from
rat hypothalamic explants (211;234). Low dose infusion of insulin into the third ventricle
of rams fed a restricted diet or diabetic male lambs increases LH pulse frequency to
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values that are similar to controls (235;236). Withdrawal of insulin from diabetic male
lambs previously receiving insulin treatment for 24 hours decreases LH pulse frequency
whereas re-supplementation of insulin restores LH pulse frequency. After 96 hrs of
insulin withdrawal in these lambs, stimulation of LH pulsatility by insulin replacement
was exaggerated (237). In contrast, insulin injection into the lateral cerebral ventricle did
not increase LH secretion in growth-restricted, hypogonadotropic lambs (238).
Insulin also affects differentiation of porcine granulosa cells by potentiating basal
and gonadotropin-induced progesterone production by enhancing FSH-stimulated LH
receptor induction (239). Pharmacological concentrations of insulin enhance basal and
LH-stimulated progesterone levels and androstenedione accumulation in cultures of
porcine thecal tissue (240). These effects may be mediated by insulin binding to IGF
receptors. It should be noted that studies using insulin are often difficult to interpret since
insulin influences the concentration of many other hormones and metabolic factors,
especially that of glucose.
3.c.) Glucose
Glucose has long been a favored candidate as the metabolic link between nutrition
and reproduction (122). Glucose is maintained within a narrow concentration in the
blood, as demonstrated by the rapid return of circulating glucose levels to baseline
following a postprandial increase.

It is the primary metabolic fuel used in ATP

production by cells and is the only significant energy-yielding substrate utilized by the
brain (241). Thus, glucose levels or availability directly affect activity of the central
nervous system (174). In addition, neural activity may also be directly altered by changes
in glucose availability since glucose is the precursor for a number of neurotransmitters,
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including glutamate, aspartate, GABA, glutamine, and alanine (174). Glucose is sensed
centrally with a large body of evidence supporting a role for the brainstem as a
glucosensing region. Lesions to the area postrema (AP) and nucleus of the solitary tract
(NTS) in the brainstem block hypoglycemia-induced increases in feeding behavior in rats
(242).

The AP is outside the blood-brain-barrier, so it is well positioned to sense

circulating concentrations. Therefore it is possible that glucose availability is detected in
the lower brainstem and the information is relayed to rostral structures controlling both
GnRH secretion and food intake. However, there is also evidence to suggest that neurons
of the VMH and LHA sense glucose (243). The relative role of the brainstem and
hypothalamus in glucosensing has yet to be determined and is a matter of some debate.
Glucose utilization and availability affect the functioning of the reproductive axis,
and therefore glucose meets the three requirements for a signal linking nutrition and
reproduction. Schneider and Wade (173) demonstrated that blockade of glycolysis in
combination with fatty acid oxidation resulted in immediate cessation of estrous cycles in
obese hamsters.

Given the importance of pulsatile LH secretion in control of

reproductive activity, it seems plausible to propose that availability of oxidizable
metabolic fuels such as glucose or ketones may impact hypothalamic control of LH
release. Nutritionally anestrous cows have lower serum concentration of glucose, along
with lower insulin and higher nonesterified fatty acids, than cows on a maintenance diet
(244). Inhibition of fat and glucose metabolism depresses pulsatile secretion of LH in
female lambs (245). In ewes, insulin-induced hypoglycemia inhibits LH secretion and
administration of glucose reverses this effect (189;246) and glucose stimulates LH
release in growth-restricted wethers (247). Intravenous infusion of 2-Deoxy-D-Glucose
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blocked the expression of estrous behavior and ovulation in cows (248) and reduced the
magnitude of estradiol-induced surges of LH in anestrous sheep (249). In addition, in
rats and lambs, 2DG decreases LH pulse frequency to values typically seen in
undernourished animals (250;251). Treatment with 2DG also prevented the occurrence
of estrous and the formation of corpora lutea in beef heifers (248). These actions appear
to be centrally mediated, since GnRH administration stimulated LH secretion in 2DGtreated animals and controls to a similar extent (189). Collectively these studies lead to
the idea that neurons controlling pulsatile release of LH may be sensitive to the
availability of oxidizable metabolic fuels (122).
3.d.) Thyroid Hormone
Thyroid hormones are another class of hormones that meet the requirements for a
nutritional signal. Nutrition can profoundly alter the synthesis, secretion, peripheral
metabolism, and function of thyroid hormones.

Weight loss and energy restriction

reduces serum T4 and T3 in several species (160;252-255). Conversely, during dynamic
weight gain serum T4 and T3 increases (253;256). There is apparently a change in
hypothalamic and/or pituitary responsiveness to feedback inhibition from circulating
thyroid hormones during undernutrition since TSH levels remain the same or even drop
during starvation (257), and there is a blunted TSH response to TRH (258). Changes in
T3 seen with changes in nutrition seem to involve practically every level of thyroid
regulation, beginning in the CNS and ending with the final action of thyroid hormones in
the nucleus of cells. The level and composition of energy intake, including whether the
organism is in normal energy balance, are important signals directing these hormones
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(259). Thyroid hormones are lipophylic and can diffuse through the blood brain barrier,
and feedback to control the release of TRH into portal blood.
In some seasonal breeders, the thyroid gland plays an important role in
reproductive transitions. For example, thyroidectomy before the breeding season blocks
the eventual transition out of the breeding season in European starlings (260;261). This
phenomenon has subsequently been observed in other avian species (262) and in sheep
(263). Although thyroid hormones do not seem to affect the onset of the breeding season,
estrous cycles can be sustained throughout the spring-summer anestrous period in ovaryintact thyroidectomized ewes housed in a fixed photoperiod (263) and the duration of the
breeding season can be lengthened by inhibiting T4 synthesis (264).

In the

ovariectomized estradiol-treated ewe, pulsatile release of LH (265) and GnRH (266) is
maintained at high levels throughout the nonbreeding season if animals have been
thyroidectomized during the preceding breeding season. Thus, the steroid-dependent
decline in LH pulse frequency that occurs as daylengths increase depends on the presence
of thyroid hormones, and thyroidectomy around the time of maximal LH pulse frequency
prevents this decline (62). T4 appears to be essential for the increased response to
estradiol negative feedback that causes seasonal anestrous (267). There is no variation,
however in plasma TSH in ewes during changes between the breeding and non-breeding
season (263). The response to thyroidectomy can be reversed by treatment with T4,
suggesting that this hormone or one of its metabolites, such as T3, mediates the influence
of the thyroid on termination of the breeding season (266;268). In addition, constant
levels of T4 are effective, suggesting that it is a change in responsiveness to T4 or T3 that
allows the onset of anestrous and not changes in T4 or T3 per se.

31

Results from

experiments in which T4 was infused into the lateral cerebral ventricles of
thyroidectomized ewes and the aforementioned effect of T4 on GnRH release strongly
suggest that they act centrally. However, acute peripheral T4 administration does not
alter GnRH secretion in thyroidectomized ewes (269). Anderson et al. (270) tested the
response to T4 of specific areas within the hypothalamus by inserting T4 containing
microimplants into various hypothalamic areas.

When T4 was administered to the

premammilary region (PMR), and in some animals to the ventromedial preoptic area
(vmPOA), thyroidectomized animals expressed a normal decline in LH at the end of the
breeding season. Collectively, these data indicate that the actions of thyroid hormones
within specific areas of the hypothalamus are necessary for the transition into seasonal
anestrous brought about by increased sensitivity of GnRH release to estradiol negative
feedback.
3.e.) Glucocorticoids
There is a strong negative correlation between corticosteroid secretion and
nutritional status in humans, rats, and other mammalian species, suggesting that activity
of the hypothalamo-pituitary-adrenal (HPA) axis is important for regulating calorie input,
disposition, and mobilization (271). The fact that changes in corticosterone levels reflect
nutritional status, along with its influence on central food intake and reproduction make
glucocorticoids an interesting and compelling nutritional signal controlling reproduction.
The reproductive axis is inhibited at all levels by various components of the HPA
axis (272). In particular, glucocorticoids secreted from the adrenal glands inhibit GnRH
release, pituitary gonadotrophs, and the gonads.

In pursuing the argument that

glucocorticoids are paramount in mediating the inhibitory effects of stress on
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reproduction, studies have shown that administration of natural or synthetic
glucocorticoids can inhibit the secretion of the gonadotropins in sheep (273), pigs
(274;275), cattle (276), rhesus monkeys (277), and humans (278). However, it should be
noted that other studies have failed to observe an effect of glucocorticoids on LH
secretion. Treatment of ovariectomized ewes with dexamethasone for 14 days did not
decrease the secretion of LH or inhibit the LH response to GnRH; neither did cortisol nor
dexamethasone treatment affect the generation of the LH surge in intact ewes (279). In
intact rams, an infusion of cortisol for 9 hours did not affect the LH response to GnRH
(280). These differences in LH response to glucocorticoids as compared to those of
Juniewicz et al. (273) may be due to the short treatment period in Fuquay et al. (280) or
sex differences in the case of Phillips et al. (279).
The influence of cortisol on LH secretion may depend upon steroid millieu.
Daley et al. (281) reported no change in LH following cortisol administration in castrated
rams. However, infusion of castrated rams with a combination of cortisol and estradiol
decreased the frequency of LH pulses in these animals more so than estradiol alone.
Infusion of estradiol into castrated rams also increased tissue concentrations of GnRH
receptor and GnRH receptor mRNA, and cortisol infusion reduced these responses
(281;282). These authors speculated that cortisol affects GnRH release by altering its
response to estradiol.
The ability of glucocorticoids to affect reproduction also appears to depend upon
the duration and route of administration. Application for 7-16 days of acute stressors that
activate the HPA axis did not impair reproduction in the pig (283). Consistent with this
finding, repeated i.v. injection of cortisol for eight days had no effect on LH secretion in
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ovariectomized pigs, even in the presence of estradiol (274). A subsequent study showed
that a similar cortisol treatment paradigm did not influence generation of the LH surge,
estrous behavior, or ovulation in gilts (275).

In contrast, sustained high cortisol

concentrations achieved through intramuscular injections of cortisol twice daily for eight
days impaired the secretion of LH in ovariectomized pigs in the absence, but not the
presence, of estradiol but only on the eighth day of treatment (274). In intact pigs,
sustained elevations of cortisol also impaired estrus expression, generation of the LH
surge, and ovulation (275). Similarly, monkeys (277) and humans (284) require high
doses of cortisol for extended periods of time to impair reproduction.

The site of

glucocorticoid action on the reproductive axis appears to lie centrally. In intact rams,
neither cortisol nor dexamethasone had an affect on either basal or GnRH-stimulated LH
(273;280). These results support the concept that corticosteroids do not directly affect
secretion of LH by the pituitary, but act at the level of the hypothalamus.
In summary, increased secretion of glucocorticoids is not always associated with
decreased secretion of the gonadotropins, particularly in cases of acute stress.
Furthermore, there may be species differences in the extent to which glucocorticoids
inhibit the secretion of LH. Finally, sex and sex steroid status may influence the effects
that glucocorticoids have on GnRH and gonadotropin secretion (285).
3.f.) Leptin
The ob/ob mouse has a homozygous mutation in the obese gene and is
hyperphagic, hyperinsulinemic, hyperglycemic, infertile, exhibits abnormally low energy
expenditure, and is morbidly obese (286;287).

Based on classic parabiosis studies,

Coleman et.al. (288) suggested that ob/ob mice lack a blood-borne factor that could
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regulate adiposity by modulation of appetite and metabolism.

This prediction

subsequently proved true as that hormone was cloned and sequenced by Zhang et.at.
(289) and called leptin, from the greek word leptos, meaning thin. Circulating levels of
leptin are derived largely from secretion by adipocytes and this hormone plays an
important role in regulating body weight and metabolism (290-292). Plasma leptin levels
are proportional to body adiposity (293) and leptin potently reduces food intake, body
weight and adipose mass when injected into leptin-deficient or normal mice (290-292).
Thus, Zhang et al. (289) proposed that leptin acted as an adipostatic hormone whose
primary function is to combat obesity. However, leptin levels decrease with fasting (160)
and other studies have shown that prevention of the decrease in leptin seen with fasting
blunts the activation of the HPA axis and prevents the suppression of the thyroid,
reproductive and growth hormone axes (151;160;294-296). Consequently, Frederich et
al. (297) proposed that leptin acts as a starvation signal. In truth, leptin undoubtedly
serves both purposes, though its more predominant actions probably lie in its function as
a signal of reduced energy balance.
A large body of evidence suggests leptin can influence reproduction.

Mice

overexpressing leptin reach puberty earlier, despite a leaner phenotype (298). On the
other hand the ob/ob mouse, which lacks leptin, is infertile. Infertility from this mutation
is believed to be due to reduced circulating gonadal steroids (299), likely due to
insufficient hypothalamic-pituitary drive (300). Obesity in another genetic model, the
db/db mouse, results from the absence of a specific isoform of the leptin receptor
important for intracellular signaling (301-303). These mice are totally insensitive to the
effects of leptin on food intake. Not surprisingly, these mice, like ob/ob mice, are
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hyperphagic, show decreased energy expenditure and morbid obesity, and are infertile
(287). A leptin receptor mutation similar to the db/db mutation in mice, occurs very
rarely in humans (304). These individuals are hyperphagic, morbidly obese, and exhibit
abnormal pubertal development (304). Thus, without question, the presence of leptin is
required for normal reproductive competency.
Whether leptin acts as a signal for puberty onset, versus being merely permissive,
is a matter of some debate. Leptin has been implicated in timing the onset of puberty in
rodents (305-307), monkeys (308), and humans (309;310). However, work in the rat has
shown that leptin did not advance the age of puberty (307), suggesting that leptin is not
the primary trigger initiating puberty in this species. Leptin concentrations also do not
change at the time of puberty in rats (311) and increase only after increases in LH at
puberty in monkeys (112), indicating that leptin does not have the characteristics to be
considered a signal for the onset of puberty. Thus, more work is needed to determine the
exact nature of leptin’s role in the reproduction of well-nourished individuals. It is clear,
however, that leptin can restore reproductive function during undernutrition. Following
fasting, monkeys (312), prepubertal heifers (313), and rats (314) being treated with leptin
had higher mean LH levels than controls and leptin can restore estrous cycles in fasted
mice (160).
The signaling form of the leptin receptor (ObRb) has been found at all points
along the HPG axis (315). Distribution of ObRb in the brain varies among species, but
all species studied thus far express ObRb mRNA in the arcuate nucleus and ventromedial
nucleus of the hypothalamus (312), two areas acknowledged to be involved in regulating
feeding and reproductive behavior. Leptin has been shown to stimulate GnRH secretion
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from hypothalamic explants (316) and reduce fasting-induced decreases in GnRH pulse
frequency (314). Yet experiments in the rat (317) and monkey (294) show little coexpression of ObRb and GnRH protein or mRNA, suggesting an indirect mechanism of
action for leptin-induced GnRH release. An effect of leptin on reproduction also may be
due to its influence on metabolic fuel availability. ObRb is located in gluco-sensitive
areas of the hypothalamus and brainstem and leptin has been shown to influence these
gluco-sensitive neurons, which could then potentially influence GnRH secretion. Leptin
may also work via the GH/IGF-1 axis to mediate GnRH release, as the fasting-induced
decrease in GH secretion was prevented by leptin treatment in rats (296;318). Leptin
restored both LH and GH secretion in castrate male sheep that had been fasted for 78 hr
(319).
Leptin may also have a direct effect on pituitary release of LH. ObRb is expressed
in the anterior pituitary and leptin stimulates gonadotropin release from rat anterior
pituitary fragments in vitro (316). Maciel et al. (313) have shown leptin to increase the
pituitary’s responsiveness to GnRH. In the gonads, leptin has been shown to regulate
mRNA expression for side chain cleavage enzyme and 17-α-hydroxylase (315), enzymes
involved in steroid synthesis, and to modulate LH-stimulated estradiol production by the
ovary (320). Leptin receptors are also present in rodent leydig cells and leptin has been
reported to inhibit basal and stimulated testosterone production in vitro (321). Leptin
levels are negatively correlated with basal and stimulated testosterone levels in humans
(322). Leptin may also affect reproduction via the HPA axis. Leptin treatment of wildtype mice prevents fasting-induced increases in corticosterone and suppression of estrous
cycles (160).
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In summary, leptin is an adipocyte-derived hormone that is critical for both
normal body weight regulation and reproductive development. Whether leptin plays an
active role in puberty onset or is simply permissive remains to be determined. What
seems to be clear is that leptin drops precipitously with undernutrition and leptin
replacement restores reproductive function. Thus leptin may be an important “metabolic”
hormone linking nutrition with reproduction.

4) Central Integration of Reproductive and Nutritional Cues
4.a.) Hypothalamus
Special subsets of neurons within the hypothalamus are sensitive to circulating
nutrients that reach them. There are glucosensitive neurons in the VMH and lateral
hypothalamus and some neurons in these areas are responsive to not only glucose but
amino acids and fatty acids as well (323). Some hormones, notably leptin and insulin, are
actively transported into the brain and receptors for both leptin and insulin are expressed
in areas of the hypothalamus important for regulating food intake. Other hormones, such
as glucocorticoids, may modulate the responses to these signals.

Food deprivation

decreases the number of estradiol responsive immunoreactive cells in the VMH and
increases numbers of these cells in the Arc and POA (324). The hypothalamus also
receives neural input from several areas, notably the nucleus tractus solitarius and area
postrema in the brainstem, that relay many neural and hormonal signals from the
periphery and/or gastrointestinal tract (325).

To influence reproduction, nutritional

signals must be transduced into neural inputs that then influence GnRH neuronal activity.
Although there are many likely candidates, NPY is a particularly attractive one.
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4.a.1. NPY and Food Intake
Neuropeptide Y (NPY), a 36 amino acid member of the pancreatic polypeptide
family, was first isolated in 1982 (326;327). In the brain, NPY is expressed at high levels
in the arcuate nucleus of the hypothalamus, nucleus accumbens, septum, and the
periaqueductal gray matter, as well as in lesser amounts in the hippocampus, amygdala,
thalamus and basal ganglia (328). Most of its metabolic effects, however, arise from
cells located within the hypothalamus (329).
NPY is one of the most powerful known endogenous stimulators of food intake.
NPY neurons found in the Arc that project to the PVN (paraventricular nucleus) are
responsible for the stimulatory effects of NPY on feeding behavior (330;331). This
member of the pancreatic polypeptide family interacts with at least six distinct G proteincoupled receptors designated Y1, Y2, Y3, Y4, Y5, and y6 (332). The Y1 receptor has a high
affinity for NPY and its mRNA and receptor protein is abundantly expressed in many rat
and mouse brain regions, including hypothalamic centers controlling energy homeostasis
(333-335). Receptor Y5 has also been implicated in mediating NPY's effects on food
intake, with receptor mRNA discreetly localized in the arcuate nucleus and PVN of the
rat and mouse brain (334-336). Intracerebroventricular administration of NPY stimulates
food intake, presumably via the Y5 receptor and at least some of the other NPY receptor
subtypes in the hypothalamus (337;338).
Acutely, NPY stimulates food intake, even in satiated animals, for hours
following central administration (339-342).

When administered chronically, NPY

induces a state mimicking hormonal and metabolic changes seen in obesity (343).
Indeed, repeated (344) and continuous (345) administration of NPY into hypothalamic
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sites produces obesity. NPY provides such a strong motivation to eat that NPY-treated
animals will carry out operant behaviors such as lever pressing and will endure electric
shocks in order to obtain food (346). Both secretion and content of NPY in the PVN
increases in rats with a robust drive for feeding following fasting (331). NPY returns to
control levels upon initiation of feeding (347) and its release is closely associated with
the energy requirements of the rats (331).

Studies of ovariectomized sheep living

outdoors indicate that changes in the expression of NPY mRNA and NPY peptide levels
in the arcuate correlate with seasonal changes in voluntary food intake (64;348).
4.a.2.) NPY and Reproduction
NPY influences GnRH release and potientates the responsiveness of
gonadotrophs to GnRH (349). NPY may also be involved in mediating steroid negative
feedback on GnRH release. NPY alters GnRH and LH release (67;146-148) and NPYcontaining neurons synapse directly onto GnRH neurons (149). Although GnRH neurons
themselves have not been shown to contain ERα or androgen receptors, NPY neurons do
coexpress ERα (150). Thus, steroid-induced changes in GnRH and LH release may, at
least in part, be due to altered input from the NPY system.
Whether NPY stimulates or inhibits GnRH/LH secretion depends somewhat on
the context in which it is examined. Much of the work has been done in females and a
large body of evidence suggests that NPY is stimulatory to GnRH release during the
follicular phase/preovulatory LH surge.

In the rat, NPY mRNA and protein levels

increase at the time of the preovulatory LH surge (350-353) and reducing NPY input can
attenuate or block the LH surge (349;354). Data are more limited in other species, but
generally support a stimulatory role for NPY in generation of the GnRH surge for sheep
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(355-357), monkeys (358;359), and mice (360). In contrast, the influence of NPY on
tonic LH release varies and depends upon the particular species examined. In rats, the
role of NPY appears to depend upon the prevailing steroidal environment. NPY inhibits
GnRH/LH release in ovariectomized rats but stimulates GnRH/LH release in steroidtreated animals (360-364). In monkeys, perfusion of the median eminence with NPY
stimulates GnRH release in males and females regardless of the presence or absence of
steroids (148;365).

In domestic livestock species, the influence of NPY on tonic

GnRH/LH secretion seems to be uniformly inhibitory. NPY inhibits LH secretion in
ewes or cows that are ovariectomized or ovariectomized and implanted with estradiol
(17;67;115;147;366).
NPY-containing neurons synapse directly onto GnRH neurons (149). One site of
action of NPY resides in the mPOA where synaptic links between immunopositive NPY
axon terminals and soma containing GnRH have been observed (367). The NPY network
also communicates directly or indirectly through other efferents with the GnRH network
in the ME-Arcuate as NPY readily stimulates GnRH release from nerve terminals in the
ME (361). Thus experimental evidence to date is consistent with the view that the NPY
network in the arcuate nucleus/median eminence and the mPOA represents an integral
link in the neural circuitry regulating GnRH secretion.
4.a.3.) Seasonal Changes in NPY
Relatively few studies have examined NPY in a seasonal context, but these
studies suggest that NPY gene and protein levels change in a season-dependent manner.
Hypothalamic NPY-containing cell numbers and NPY mRNA expression is higher
during the breeding season in ovariectomized ewes, and estradiol did not influence this
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response (348;368).

Skinner and Herbison (369) observed that numbers of

immunoreactive NPY neurons are increased during the mid-luteal phase of the estrous
cycle compared to anestrous. Clarke et al. (370) observed that NPY mRNA levels
increased during a long-day photoperiod in intact male sheep. While these studies clearly
suggest that hypothalamic NPY levels change with daylength, it is not possible to
determine the exact stimulus for these changes. It may be that NPY input can be altered
directly by changes in photoperiod. Also, differences in NPY levels could potentially be
explained by differences in the steroid milieu that prevails during the mid-luteal phase of
the estrous cycle (e.g. progesterone) compared to anestrous (e.g. estradiol).
Alternatively, since NPY is an important regulator of food intake and metabolism,
changes in ambient temperature or other environmental factors could affect expression.
Therefore, one aspect of my thesis investigates the relationship between NPY mRNA
expression and LH secretion during different photoperiods and steroid environments in
male sheep.
4.a.3.) Sex-differences
Sex-related differences exist in response to various energy states and
hypothalamic neuropeptides known to be involved in controlling food intake, and
potentially linking nutritional changes to reproductive changes. Interestingly, female
NPY knock-out mice respond more robustly than male NPY knock-out mice to leptin
(371;371) and NPY appears to be responsible for a greater percentage of obesity in
females than males when NPY knock-out mice are crossed onto an ob/ob background
(371). In ob/ob mice lacking NPY, one third of the females were fertile compared to only
5% of the males (371). Since ob/ob mice are always infertile, this finding suggests that
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NPY may play a role in leptin deficient infertility to a greater degree in females than
males. NPY-Y2 receptor knock-out mice of both sexes show a decrease in body weight
relative to controls, yet food intake is decreased in males and increased in females (372).
NPY-Y1 receptor deletion caused a fourfold increase in fat mass as a percentage of body
weight in females, but no increase in males.
4.b.) brainstem
In addition to the hypothalamus, the brainstem may play an important role in
linking nutrition and reproduction. The area postrema (AP) and nucleus of the solitary
tract (NTS), both within the brainstem, transmit metabolic information to hypothalamic
areas that influence GnRH release. The AP is ideal for sensing peripheral metabolic
information because it lacks a distinct blood-brain-barrier (373). Ritter et al. (374) have
defined more specific sites within the hindbrain that are glucosensitive. These areas in
the dorsomedial region are intimately associated with the fourth ventricle, in close
proximity to the AP, and the ventrolateral sites are close to an area on the ventrolateral
surface of the medulla that has been shown to have a higher local glucose utilization rate,
higher blood flow, and a greater density of perfused capillaries than surrounding
medullary tissue (375). These are areas very well suited for sensing peripheral glucose
concentrations and neuronal cell bodies in the AP-NTS project to the rostral structures of
the brain, including the PVN and lateral hypothalamus, which are implicated in the
regulation of feeding and reproduction (376).

Therefore it is likley that peripheral

metabolic signals are detected here and the information is relayed to rostral structures
controlling both GnRH secretion and food intake. Indeed, neural elements of the AP are
necessary for glutamate-induced feeding (377).
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Caudal brainstem structures have been suggested to mediate the suppressive effect
of glucoprivation induced by 2DG on pulsatile LH secretion in the rat. Infusion of very
low doses of 2DG into the fourth ventricle will suppress LH secretion in the rat (373).
The AP mediates the suppression of pulsatile LH secretion in response to insulin-induced
hypoglycemia (378).

AP lesions block metabolic inhibitor-induced suppression of

estrous behavior as well as the associated decrease in ER immunoreactivity in the VMH
(324). These authors suggested that estrogen-binding cells in the VMH, critical for
induction of lordosis in hamsters, receive information about metabolic fuel availability
via the AP. Similarly, AP lesions block 2DG-induced inhibition of estrous cycles in
Syrian hamsters (379). Specifically lesioning catecholaminergic neurons that project
from the brainstem to the PVN eliminate the increased length of estrous cycles seen
during glucoprivation (380) Thus the brainstem seems to play an essential role during
limited glucose availability with regard to inhibiting estrous behavior and expression of
estrous cycles, at least in rodent models studied thus far.
Table 1
Effect of neurotransmitters that mediate steroid negative feedback on
GnRH/LH secretion
inhibitory
Barb et al. (381)
β-endorphin
**
Norephinphrine
inhibitory
Havern et al. (382), Riggs
and Malven (383)
*
Dopamine
inhibitory
Lehman et al. (384), Havern
et al. (382)
NPY
inhibitory/
Bauer-Dantoin et al. (146),
stimulatory# Woller et al. (148), BarkerGibb et al. (67), Malven et
al. (147)
inhibitory
Ferreira et al. (385;386)
γ-aminobutyric acid
glutamate
stimulatory
Caraty et al. (387)
* May only have effect during anestrous
** NE is necessary for the LH surge to occur
# Dependent on species
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Chapter 2

NEUROPEPTIDE Y GENE EXPRESSION IN MALE SHEEP:
INFLUENCE OF PHOTOPERIOD AND TESTOSTERONE
Abstract
The frequency of pulsatile release of gonadotropin-releasing hormone (GnRH) and LH is
high in the breeding season and low in the nonbreeding season. These alterations in the
patterns of GnRH and LH release are due to an interaction of daylength and gonadal
steroid negative feedback. A vast amount of data indicates that steroid-responsive neural
systems play a role in regulating seasonal changes in GnRH release. One candidate
system is neuropeptide Y (NPY).

To determine the independent and interactive

influences of photoperiod and steroid exposure on NPY mRNA levels, we used
hypothalamic tissue from four groups (n=4 per group) of castrated male sheep that were
simultaneously housed in photochambers and exposed to: 1) a 16L:8D photoperiod (LD),
2) LD and implanted with testosterone (LD+T), 3) a 10L:14D photoperiod (SD), and 4)
SD+T. Circulating levels of T averaged 2.8±0.2 ng/ml in implanted animals, but were
undetectable in nonimplanted males. Mean LH levels were significantly reduced (P<0.01)
in the LD+T group compared to the other groups which did not differ from each other.
Silver grain area per NPY neuron in the arcuate nucleus, as assessed by in situ
hybridization, was inversely related to mean LH values with grain area per cell being
significantly greater (P<0.05) for LD+T males than all other groups, which did not differ
from each other. NPY cell numbers were not significantly different (P>0.10) among
treatment groups. These results show that NPY expression is increased in male sheep
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during a LD photoperiod in a T-dependent manner. Our data are consistent with the idea
that NPY is involved in seasonal regulation of GnRH and LH release in the male sheep.
Introduction
Sheep are seasonal breeders that exhibit reproductive activity during the relatively
shorter days of fall and early winter and transition into reproductive quiescence during
the lengthening days of late winter or early spring (388;388). These seasonal swings in
reproductive activity are due to changes in pulsatile patterns of gonadotropin hormone
releasing-hormone (GnRH), and thus, luteinizing hormone (LH) secretion. During the
breeding season, pulsatile GnRH and LH secretion exhibits a high frequency pattern of
release whereas during the nonbreeding season, GnRH and LH secretion is characterized
by a low-frequency pattern of release. These alterations in the patterns of GnRH and LH
release are due to an interaction of daylength and gonadal steroid negative feedback (389393). However, the neural mechanisms whereby steroids and photoperiod interact to
control GnRH and LH secretion are not completely understood.
Whether steroids directly influence GnRH release by acting directly at GnRH
neurons has been a matter of much study. The fact that GnRH neurons apparently
contain few, if any, estrogen receptor (ER)-α or androgen receptors (394;395) has led to
the idea that gonadal steroids do not act directly to influence GnRH release. However, it
has recently been reported that GnRH neurons coexpress mRNA and protein for ER-β
(396-399), another ER isoform. This raises the possibility that estradiol may directly
influence GnRH neural cell function, although the nature of that effect has not been
clearly established in vivo. Clearly, however, steroids influence GnRH release through
other steroid-responsive neurons.

Neuropeptide Y (NPY), a 36 amino acid peptide
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synthesized and prevalent in the arcuate nucleus (400-402), is one candidate. NPY alters
GnRH and LH pulsatility (403-406) and NPY-containing neurons synapse directly onto
GnRH neurons (407).

In addition, NPY neurons coexpress ERα (408).

Thus,

photoperiod-induced changes in GnRH and LH release may, at least in part, be due to
altered input from a steroid-responsive NPY system.
The relatively few studies that have examined NPY in a seasonal context suggest
that NPY mRNA and protein levels change in a season-dependent manner. Clarke et al.
(409) observed that NPY mRNA levels increased during a long-day photoperiod in intact
male sheep. In female sheep, hypothalamic NPY-containing cell numbers and NPY
mRNA expression was higher during the breeding season in ovariectomized ewes, and
estradiol did not influence this response (410). Skinner and Herbison (411) observed that
numbers of immunoreactive NPY neurons in ewes are increased during the mid-luteal
phase of the estrous cycle compared to the nonbreeding season. While these studies
clearly suggest that hypothalamic NPY levels change with daylength, it is not possible to
determine if these changes are due solely to photoperiod or if they may also be influenced
by ambient temperature or steroid environment. In order to determine the independent
and interactive influences of photoperiod and steroid exposure on NPY mRNA levels, we
used hypothalamic tissue from males that were contemporaneously exposed to either long
or short daylengths in the presence or absence of testosterone.

Materials and Methods
Tissues used in this study were taken from animals used in a previously published
report (412).

Twenty black-faced sheep, predominantly of the Suffolk breed, were
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housed at the Veterinary Research Farm at the University of Illinois, Urbana (Latitude
40o N) and maintained in light-sealed photochambers that were partially controlled for
temperature by air conditioners and heating units. They were fed alfalfa hay and allowed
water ad libitum. All procedures were carried out in accordance with NIH Guidelines for
the Care and Use of Laboratory Animal Care.
Eight males were long-term castrates (>6 months) while 12 were castrated 1
month prior to the beginning of the experiment. Animals were assigned to one of four
treatment groups with assignment balanced for time postcastration: 1) short day
(8L:16D), no testosterone (SD), 2) short day with testosterone (SD+T), 3) long day
(16L:8D), no testosterone (LD), and 4) long day with testosterone (LD+T). The LD
groups entered photochambers on September 21 and were subjected to 90 days of
16L:8D followed by 90 days of 8L:16D and then a final 90 days of 16L:8D. The SD
groups were left outdoors until December 21 whereafter they were subjected to 90 days
of 16L:8D followed by a final 90 days of 8L:16D. LD and LD+T animals were put
through successive photoperiod treatments to phase reverse the change in LH secretion so
that all animals could be sacrificed at a similar time and ambient temperature, but under
contrasting photoregimens.
Animals receiving testosterone were implanted as previously described (413) on
December 21. To validate the LH response to photoperiod and determine circulating
testosterone levels, blood samples were collected twice weekly via jugular venipuncture
during the last 3 weeks of the final photoperiod treatment and assayed for plasma T and
LH as previously described (414). At the end of the study, animals were euthanized with
an overdose of barbiturate and hypothalami were quickly excised. Tissue was frozen
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quickly on dry ice and stored at –70oC until sectioned on a cryostat and used for in situ
hybridization.
In situ hybridization
Radiolabeled cRNA probes for ovine NPY mRNA were generated from a 311 bp
cDNA sequence kindly provided by Dr. Duane Keisler (University of Missouri,
Columbia MO). Probes were labeled with 35S-UTP and tissue sections were processed as
previously described (23-24). Tissue sections through the arcuate nucleus were
hybridized under glass cover slips overnight at 55oC with labeled cRNA (5 X 105 cpm/40
µl hybridization buffer/section). Post-hybridization washes were performed as described
by Greco et al. (415). Tissue sections then were dipped in autoradiographic emulsion
(NTB3; Kodak, Rochester NY) diluted 1:1 with deionized H2O. Sections were exposed
for approximately 10 days at 4oC, and then developed with Dektol developer and Kodak
Fixer. Finally, tissue sections were counterstained with 0.08% Toluidine-O Blue and
coverslipped with Depex. Hybridization controls on test tissues included hybridization
with labeled ‘sense’ strand cRNA probes. No hybridization signal was detected on these
tissues.
Sections of the arcuate nucleus from each animal were anatomically matched
according to the arcuate shape and relation to the third ventricle, and a researcher
unaware of the treatment groups analyzed two of these sections. Due to the large number
of NPY containing cells, only one side of each section was analyzed. Results obtained
were an average of these two hemi-sections. Silver grain area above individual neurons
was determined at 40X using the public domain program NIH Image (developed at the
US

National

Institutes

of

Health

and
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available

on

the

Internet

at

http://rsb.info.nih.gov/hin-image/). Light intensity and threshold were set and maintained
for all animals. For each animal, silver grains above individual neurons were digitized on
screen and the area occupied by the grains minus the background was determined.
Statistical analysis
NPY silver grain area per neuron and cell number were calculated for each animal
and then averaged among animals to derive treatment group means.

Values were

compared using a two-way analysis of variance with the model including steroid,
photoperiod and the steroid x photoperiod interaction. Comparisons between individual
treatment groups were performed by the test of Least Significant Difference.
Results
LH and Testosterone
As previously reported (416), LH values were significantly lower (P<0.01) in the LD+T
group (all below assay sensitivity of 2.0 ng/ml) compared with all other treatment groups.
LH values did not differ (P>0.10) among SD (14.94±1.16 ng/ml), SD+T (15.32±0.66
ng/ml) and LD (16.49±1.16 ng/ml) groups. Circulating testosterone concentrations in
testosterone-implanted males were 2.75±0.16 ng/ml. Testosterone levels were below
assay sensitivity (1.0 ng/ml) in males without T implants.

NPY mRNA Expression and Cell Numbers
Photomicrographs from individual animals representing each treatment group are shown
in Figure 1. Group means for silver grain area per neuron and cell numbers are shown in
Figures 2 and 3, respectively. Silver grain area per NPY neuron was inversely related to
mean LH values with grain area being significantly greater (P<0.05) for LD+T animals
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than all other groups. Grain area did not differ significantly (P>0.10) among LD, SD,
and SD+T. NPY cell numbers did not differ among groups (P>0.40).

Discussion
Our study is the first to examine the independent influences of photoperiod and
testosterone on NPY gene expression in the arcuate nucleus of the sheep. The results
suggest that testosterone alters NPY gene expression during a long-day, but not shortday, photoperiod. Interestingly, NPY mRNA levels inversely reflected mean LH values
in our study, i.e. LH values were reduced only in the group expressing significantly
higher NPY mRNA levels. These data suggest that reductions in LH secretion resulting
from photoperiod-induced increases in sensitivity to testosterone negative feedback may
be mediated, at least in part, by elevated NPY.
The inverse relationship in our study of mean LH values and NPY mRNA
expression suggests that NPY inhibits LH secretion. Whether NPY stimulates or inhibits
GnRH/LH secretion depends somewhat on the context in which it is examined. Much
work has been done in females and a large body of evidence suggests that NPY is
stimulatory to GnRH release during the follicular phase/preovulatory LH surge. In the rat,
NPY mRNA and protein levels or NPY-Y1 receptor mRNA levels increase at the time of
the preovulatory LH surge (417-421) and reducing NPY input can attenuate or block the
LH surge (422;423). Data are more limited in other species, but generally support a
stimulatory role for NPY in generation of the GnRH surge for sheep (423-425), monkeys
(426;427) and mice (428). In contrast, the effect of NPY on tonic LH release varies and
depends upon experimental conditions. In rats, the role of NPY appears to depend upon
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the prevailing steroidal environment since NPY inhibits GnRH/LH release in
ovariectomized rats but stimulates GnRH/LH release in steroid-treated animals (429433). In monkeys, perfusion of the median eminence with NPY stimulates GnRH release
regardless of steroid milieu (434-436). Interestingly, NPY delivered to the third ventricle
inhibits GnRH release (437) suggesting that the influence of NPY on GnRH release may
be site-specific in this species. Consistent with our data, the influence of NPY on tonic
GnRH/LH secretion seems to be uniformly inhibitory in domestic livestock species.
NPY inhibits LH secretion in ewes or cows that are ovariectomized or ovariectomized
and implanted with estradiol (438-443). This is consistent with the elevation in NPY
gene expression normally observed during food restriction in both male (444) and female
sheep (445), periods that are characterized by low levels of tonic LH secretion, and
agrees with our observation that NPY mRNA levels were inversely related to mean LH
levels.
To our knowledge, ours is the first report to examine the effect of testosterone
within short and long days on NPY mRNA expression in domestic livestock species.
Clarke et al. (446) observed that arcuate NPY mRNA levels increased during long days
in intact male sheep. We also observed an increase in NPY gene expression during long
days, but only in response to testosterone, suggesting that photoperiod by itself is not a
sufficient stimulus. Our data are consistent with previous work showing that testosterone
stimulates NPY. In humans, NPY levels decrease with antiandrogen treatment (447) and
increase in women with polycystic ovarian syndrome who exhibit increased circulating
testosterone levels (448). In rats, castration reduces and testosterone stimulates NPY
mRNA and protein levels (449-454). However, our data are at odds with that observed
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for monkeys wherein castration or treatment with testosterone does not affect NPY
mRNA levels (455;456), suggesting that species differences exist in the effects of
testosterone on NPY input.
There appears to be a significant sexual dichotomy in the regulation of NPY by
photoperiod and steroids. As mentioned above, testosterone stimulates NPY gene and
protein expression in male rats and we found that NPY mRNA levels increased only in
LD+T animals. In contrast, work in the ewe (457) shows that seasonal changes in NPY
mRNA or protein expression are steroid-independent and actually increase during short
days, e.g. the breeding season. Furthermore, NPY levels in female rats were observed to
be only half that of male rats (458) and several studies have reported an inhibitory effect
of estradiol on NPY mRNA or peptide levels in female rats (459-462). Thus, it may be
that NPY mRNA and protein levels are suppressed in the estradiol-dominated female
while they are stimulated in the androgen-dominated male. Sexually dimorphic NPY
levels may, at least in part, be due to the metabolism of testosterone to
dihydrotestosterone (DHT) via the enzyme 5α-reductase in males.

We previously

showed that conversion of testosterone to DHT is an important step in inhibition of LH
secretion by testosterone (463). While the influence of DHT on NPY has not been
directly assessed, like testosterone, DHT prevents cold-induced loss of body weight
(464), increases body mass (465), and increases food intake (466;467) raising the
possibility that DHT may mediate, at least in part, metabolic responses involving NPY
that are influenced by testosterone.
Although our data are consistent with the idea that daylength-induced alterations
in NPY input may play a role in regulating seasonal fluctuations in tonic LH secretion
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and fertility, they are also consistent with the notion that changes in NPY input underlie
seasonal alterations in voluntary food intake.

Castration reduces and testosterone

stimulates body weight gain, nitrogen retention, and/or food intake in a number of species
(468-478). Intact male sheep exhibit increased numbers of cells expressing NPY and
increased NPY mRNA during long days that are associated with increased voluntary food
intake (479). Furthermore, NPY is a well known, potent stimulator of food intake in
several species including sheep (480). Thus, an increase in NPY mRNA expression in
response to testosterone during long days may play a role in increasing voluntary food
intake in male sheep.
Most likely, however, is that NPY is involved in regulating both reproduction and
food intake. Nutrition and reproduction are heavily intertwined and NPY may be one
neuropeptide system linking one with the other.

In male sheep, photoperiod alters

androgenic input to GnRH neurons so that the ability of testosterone to suppress
reproduction is maximal during long days. Based on our data, we would suggest that
NPY may be part of this inhibitory pathway, while fulfilling a dual role by stimulating
voluntary food intake during this time of year when food availability is greatest.
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Figure 1
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Figure 2

Figure 3
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Figure Legends
Figure 1. Darkfield photomicrographs (10X) of the arcuate nucleus of the hypothalamus
taken from representative animals for SD, SD+T, LD, and LD+T. Sections were
exposed to a cRNA antisense NPY probe corresponding to nucleotides ------ of the
ovine NPY sequence. 3V – third ventricle.
Figure 2. NPY mRNA expression as assessed by silver grain area per neuron (µM2) for
SD, SD+T, LD, and LD+T animals. NPY silver grain area was elevated (P<0.05)
only in LD+T animals, and SD, SD+T, and LD groups did not differ significantly
(P>0.10). One side of each of two arcuate sections were assessed per animal and
values represent the mean ± SEM of 4 animals per group.
Figure 3. Numbers of NPY cells per animal for SD, SD+T, LD, and LD+T animals. Cell
numbers did not differ significantly (P>0.10) among treatment groups. One side of
each of two arcuate sections were assessed per animal and values represent the
mean ± SEM of 4 animals per group.
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Chapter 3

INFLUENCE

OF

INSULIN-LIKE

GROWTH

FACTOR-1

(IGF-1)

ON

THYROXINE (T4) AND TRIIODOTHYRONINE (T3) IN FOOD-DEPRIVED
MALE AND FEMALE SHEEP

Abstract
Three experiments were performed to test the hypothesis that IGF-1 alters circulating
levels of total T4 and total T3. For the first two experiments, we used ewes 9 months of
age, each of which was ovariectomized and implanted sc with a 1 cm estradiol implant.
In Experiment 1, ewes were food-deprived for 6 days with 3 blood samples collected
every 2h on Day 0 prior to food removal and on days 2, 4, and 6 of food withdrawal.
Beginning on Day 4, ewes received subcutaneous injections of saline (controls; n=5), or
IGF-1 at either 50 ug/kg/d (n=4) or 10 ug/kg/d (n=5) twice daily (0800 and 2000 h). For
all studies, we used long R3-IGF-1, an analog with reduced affinity for IGF-1 binding
proteins. Six days of food deprivation lowered total T4 and total T3 levels in controls.
IGF-1 elevated both total T4 and total T3 in a dose-dependent fashion by Day 6 of food
withdrawal. In Expt 2, females were food deprived for 6 days and then given intravenous
injections of IGF-1 at either 25 ug/kg (n=5), 12.5 ug/kg (n=5), or 6.25 ug/kg (n=5).
Blood samples were collected at 12-min intervals for the subsequent hour and another
sample collected at 2h postinjection. IGF-1 increased total T4 values significantly in all
groups at 60 and 120 min postinjection, but increased total T3 in all groups by 36 minutes
postinjection. In Experiment 3, castrated males that were 9 months old and implanted
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with a 1 cm estradiol implant were food deprived for 4 days. During this period, they
received either saline injections (control; n=5) or IGF-1 at 25 (n=5), 50 (n=5) or 100
(n=5) ug/kg/d given subcutaneously. Food deprivation decreased total T4 and total T3
levels. IGF-1 was able to maintain total T4 and total T3 levels for 2 days, after which
total T4 and total T3 concentrations fell to levels that were less than those on Day 0, but
still greater than those observed in controls.

In summary, IGF-1 clearly increased

circulating levels of both T4 and T3, but was more potent in females than in males.
Introduction
For most species, food supply is not constant. Instead they are often exposed to
periods of energy abundance and scarcity. To maintain homeostasis and a constant
supply of nutrients to the brain, these swings in food availability are met by a variety of
compensatory changes in endocrine and metabolic parameters (481). One such change
occurs in circulating levels of T4 and T3, which are important for determining basal
metabolic rate (482;483). Weight loss and energy restriction reduces serum T4 and T3 in
several species (160;252-255). Conversely, during dynamic weight gain serum T4 and T3
increases (253;256). This response likely represents a compensatory mechanism to slow
or speed, respectively, metabolism in order to help maintain energy balance.

The

mechanisms that regulate T4 and T3 levels during periods of altered energy balance are
not completely known. One possibility is that they may be influenced by peripheral
signals that reflect metabolic status, such as insulin-like growth factor-1 (IGF-1).
IGF-1 is synthesized in many tissues including brain, hypothalamus, pituitary, and
liver (185-187). Secretion of IGF-1 from the liver in response to pituitary-derived growth
hormone (GH) accounts for the secretion of approximately 75% of circulating IGF-1
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(484).

IGF-1 acts in endocrine, paracrine, and autocrine fashions as an integral

component of multiple systems controlling growth, differentiation, and metabolism
(200;201). IGF-1 is markedly affected by the nutritional status of an animal, decreasing
during periods of negative energy balance (204;485) and increasing during periods of
positive energy balance (486). Thus, circulating levels of IGF-1 reflect energy balance.
Reports of the effects of GH, or IGF-1, on the hypothalamo-pituitary-thyroid
(HPT) axis are relatively few, and mostly gathered from human patients with
somatotropic abberations.

GH-deficient adults (487), and children with either GH

deficiency (488) or hypopituitaryism (489) demonstrate decreased serum T4 and
increased serum T3 levels.

(490) have shown that administration of IGF-1 quickly

decreases serum TSH and causes a progressive decline in serum free T4 while T3 levels
are maintained in GH-resistant patients. Thus, while it is likely that IGF-1 influences
thyroid hormone secretion, the site(s) at which IGF-1 may act is unknown. While the
aforementioned data suggests an action at the pituitary, affects at the hypothalamus or
thyroid gland itself cannot be ruled out. Furthermore, the above studies used individuals
fed a normal diet and so the relationship between IGF-1, T4, and T3 during food
deprivation has not been examined. One purpose of these studies is to test the hypothesis
that IGF-1 stimulates T4 and T3 secretion in food-deprived animals.
Males and females respond differently to changes in energy state. It has been
hypothesized that due to gender-specific evolutionary selection pressures, female
mammals have evolved a greater capacity to conserve energy than males (152).
Accordingly food restriction has been reported to have a greater and more permanent
effect on physical growth in males than in females and in mature humans and animals,
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males are more susceptible to the adverse effects of starvation than females (491). Thus,
a second purpose of this work is to determine if the thyroid hormone response to IGF-1 is
sex-dependent.
Materials and Methods
General
All sheep used in these studies were of Suffolk or Dorset breeding and were
approximately 9 months of age. They were housed indoors in light (14L:10D) and
temperature controlled rooms and fed ad libitum a diet consisting of alfalfa pellets
supplemented with cracked corn. Animals had unlimited access to water at all times. All
procedures were approved by the West Virginia University Animal Care and Use
Committee and followed NIH guidelines for use of animals in research.
Experiment 1
The purpose of this experiment was to determine if chronic administration of IGF1 stimulates T4 and T3 secretion in food-deprived females.

Fourteen ewes were

ovariectomized two weeks prior to the beginning of the study.

At the time of

ovariectomy, each ewe received a length of silastic tubing (Sil-Med, Tri-anim, Sylmar,
CA; inner diameter 3.35mm, outer diameter 4.65mm) packed with 1 cm of crystalline βestradiol (Sigma-Aldridge Inc., St Louis MO) and closed at both ends with silicone
sealant. Two weeks prior to the study, animals were group-housed with each pen holding
five animals. Ewes were provided a normal meal on the morning of Day 0 and allowed
time to eat after which they received no food for the remainder of the 6-day period of
food withdrawal. Animals were allocated to three treatment groups with assignment
balanced for body weight on Day 0: 1) food-deprived control (n=5), 2) food-deprived and
receiving 10ug/kg/d IGF-1 (IGF-10; n=5), and 3) food-deprived and receiving 50ug/kg/d
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IGF-1 (IGF-50; n=4).

Animals receiving IGF-1 were administered long R3-IGF-1

(GroPep Ltd, Adelaide, Australia), an IGF-1 analog with reduced affinity for IGF-1
binding proteins, subcutaneously twice daily at 0800 h and 2000 h beginning on Day 4 of
food removal. Weights were recorded at 0800 h and three blood samples were collected
via jugular venipuncture every 2 hours over a 4-hour period beginning at 0900 h on days
0, 2, 4, and 6. Samples were allowed to sit overnight, were centrifuged, and the serum
was removed and frozen at -20oC. Samples were analyzed for total T4, total T3, insulin,
and glucose.
Experiment 2
The purpose of this study was to determine if IGF-1 acutely stimulates total T4
and total T3 secretion. Similar to Experiment 1, ovariectomized ewes were food deprived
for 6 days. On Day 6, IGF-1 was administered as a single intravenous bolus at a dose of
6.5 ug/kg (n=5), 12.5 ug/kg (n=5), or 25 ug/kg (n=5). Blood samples were collected
every 12 minutes from just prior to IGF-1 injection (0 minutes) to 60 minutes following
IGF-1 injection, and a single sample was collected 120 minutes post-injection. Blood
samples were processed as above and total T4 and total T3 were assessed for each sample.
Experiment 3
The purpose of this experiment was to determine the effect of chronic IGF-1
administration on T4 and T3 secretion in food-deprived males. Two weeks prior to the
study, 28 wethers were each implanted with a 1 cm estradiol implant and were grouphoused with each pen holding 6 animals. Wethers were provided a normal meal on the
morning of Day 0 and allowed time to eat after which they received no food for the
remainder of the 4-day period of food withdrawal. Wethers were divided into four
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treatment groups initially balanced for body weight on Day 0: 1) food-deprived control
group (n=6), 2) food-deprived and receiving 25 ug/kg/d IGF-1 (IGF-25; n=6), 3) fooddeprived and receiving 50 ug/kg/d IGF-1 (IGF-50; n=6), or 4) food-deprived and
receiving 100ug/kg/d IGF-1 (IGF-100; n=5).

Animals receiving IGF-1 were

administered long R3-IGF-1 (GroPep Ltd, Adelaide, Australia) subcutaneously twice
daily at 0800 h and 2000 h beginning on day 1. Weights were recorded at 0800 h and
blood samples were collected via jugular venipuncture every 2 hours over a 4-hour period
beginning at 0900 h on days 0, 2, and 4. Samples were allowed to sit overnight, were
centrifuged, and the serum was removed and frozen at -20oC. Samples were analyzed for
total T4, total T3, insulin, and glucose.
Hormone Assays
Total T4 was assessed using a commercially available kit from Diagnostic
Products Corporation (Los Angeles, CA). For males, all samples within an experiment
were run in duplicate within one assay. The intraassay coefficient of variation was 10.6%
with sensitivity being 0.1 ng/ml.

For females, three assays were performed with

sensitivity being 0.1 ng/ml and interassay and intrassay coefficients of variation being
14.3% and 7.0%, respectively. Total T3 was assessed using a commercially available kit
from Diagnostic Products Corporation. For males, all samples within an experiment were
run in duplicate within one assay. The intraassay coefficient of variation was 4.2% with
sensitivity being 2 ng/dl. For females, 2 assays were performed with sensitivity being 2
ng/dl and interassay and intrassay coefficients of variation being 7.2% and 5.5%,
respectively.

Insulin was assessed using a commercially available kit from Linco

Research Inc. (St. Charles, MO). All samples within an experiment were run in duplicate

63

within one assay. The intraassay coefficient of variation was 6.6% with sensitivity being
0.1 ng/ml. Serum glucose levels were measured spectrophotometrically in singlet using
the Trinder reagent kit and performed according to manufacturer’s instructions (Sigma
Diagnostics Inc., St. Louis MO).
Statistical Analysis
Values for individual samples were averaged to provide a mean for each animal
within each blood collection period (or day). Data for body weight, total T4, total T3,
insulin, and glucose were analyzed by two-way ANOVA for repeated measures to
determine the effects of time, dose of IGF-1, and their interaction. Those groups showing
a significant time x dose interaction were further analyzed by one way analysis of
variance followed by a test of least significance difference to determine influence of IGF1 dose among groups within each day, and by one way repeated measures followed by a
Student-Newman-Keuls test to determine the effect of time within each group over the 4
or 6 day treatment period for males or females, respectively. In addition, for Experiment
2, Dunnet’s method was used to compare post-injection time period means to the control
period (0 minutes).

Results
Experiment 1
As expected, food deprivation caused a significant (P<0.05) decrease in body
weight (Figure 1). The percent change in body weight did not differ among groups
(P>0.10). Collectively, ewes lost 14.4 ± 1.56% of their initial body weights over the 6day period of food withdrawal.
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Changes in total circulating T4 and T3 in ewes are illustrated in Figure 2A and 2B,
respectively. As expected, circulating levels of both T4 and T3 were decreased (P<0.05)
in controls by food deprivation.

In contrast, treatment with IGF-1 elevated total

circulating T4 levels by day 6 of food removal in a dose dependent manner. Total T4
levels for IGF-50 ewes were elevated (P<0.05) above their Day 0 values and were greater
(P<0.05) than Day 6 values for controls. Values for IGF-10 ewes were returned to their
Day 0 values by IGF-1 treatment and were intermediate of controls and IGF-50 ewes on
Day 6. Likewise, IGF-1 increased circulating T3 in a dose-dependent manner. Total T3
levels in all groups differed significantly (P<0.05) from each other on day 6 and total T3
was returned to Day 0 values in IGF-10 ewes and exceeded Day 0 values in IGF-50 ewes.
As expected, insulin concentrations (Figure 3A) decreased (P<0.01) in fooddeprived females. Insulin levels were lower (P<0.05) in IGF-1 treated groups compared
to controls on days 4 and 6, though there was no significant difference (P<0.10) between
IGF-1 treated groups. Glucose levels (figure 3B) dropped slightly, but significantly
(P<0.01) over time in food-deprived controls. Effects of IGF-1 on circulating glucose
levels were dependent upon dose. Glucose dropped (P<0.01) over time in the IGF-10
group, but values were not different than controls (P>0.05). Glucose levels were lower
(P<0.05) on days 4 and 6 in the IGF-50 group than either controls or the IGF-10 group.
Experiment 2
Total T4 values in ewes receiving intravenous injections of IGF-1 are shown in
Figure 4A. ANOVA revealed a significant effect of period (P<0.001), but no significant
effect of dose (P>0.60) or dose x period interaction (P>0.60). Total T4 levels were
increased (P<0.05) over 0 minute control values at 60 and 120 minutes post-injection.
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Total T3 values in ewes receiving intravenous injections of IGF-1 are shown in Figure
4B. ANOVA revealed a significant effect of period (P<0.001), but no significant effect
of dose (P>0.30) or dose x period interaction (P>0.20). Total T3 concentrations were
increased (P<0.05) over 0 minute control values at 36, 48, 60 and 120 minutes postinjection.
Experiment 3
As expected, food removal for 4 days resulted in a significant (P<0.001) loss of
body weight (Figure 5). The percent change in body weight did not differ (P>0.80)
among treatment groups with males losing 12.49 ± 0.90% of their initial body weight
over the 4 day food withdrawal period.
Total T4 values (Figure 6A) in controls progressively decreased (P<0.05) on each
day of food removal. Compared to day 0 values, Total T4 values on day 2 for IGF-25 and
IGF-50 males were not significantly different (P>0.10), but were increased (P<0.05)
slightly in IGF-100 males. Total T4 levels decreased (P<0.05) in all IGF-1 treated groups
on day 4 compared to day 2. However, total T4 was significantly (P<0.01) higher for all
IGF-1 treated groups than controls on day 2 and remained so on day 4. Total T3 levels
(Figure 6B) progressively declined (P<0.05) in both control males and IGF-25 animals.
Total T3 in the IGF-50 males did not differ from Day 0 levels until Day 4 of food removal
(P<0.05). Although total T3 levels decreased in IGF-100 males over time, this reduction
was not statistically significant (P>0.10). Total T3 levels did not differ (P>0.20) between
treatment groups on Day 2. On Day 4, total T3 values were higher (P<0.05) in IGF-50
and IGF-100 males than in control males. Total T3 levels in IGF-25 wethers were
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intermediate of those in controls and IGF-50, i.e. levels in IGF-25 males were not
significantly different (P>0.05) from either control or IGF-50 males.
Insulin levels (Figure 7A) dropped below assay sensitivity by day 2 of food
removal and remained undetectable in all groups. Circulating glucose levels (Figure 5b)
decreased (P<0.05) in control, IGF-25, and IGF-50 males on day 2 and 4 compared to
day 0. In the IGF-100 males, circulating glucose concentration on days 0 and 2 were
similar (P>0.05), but glucose levels dropped significantly on day 4 (P<0.05). Glucose
levels among groups were not significantly different (P>0.05) on Day 2. Glucose levels
were similar (P>0.05) between IGF-50 and IGF-100 males on Day 4 and both were
significantly (P<0.05) lower than either controls or IGF-25 males, which did not differ
from each other (P>0.05).

Discussion
In order to determine the effect of IGF-1 on circulating thyroid hormone
concentrations, we administered exogenous IGF-1 to food-deprived sheep in three
separate experiments, two using females and one using males. The results from these
studies support our hypothesis that IGF-1 increases thyroid hormone levels during food
deprivation. Furthermore, results from these experiments show that food deprivation has
a greater impact on males than females and that the thyroid hormone response to IGF-1
during food deprivation is much greater in females. These data are consistent with the
idea that females are much more able to cope with energy perturbations than males and
further suggest that changes in IGF-1 may provide a signal linking nutritional status with
basal metabolic rate through an alteration in circulating thyroid hormone levels.
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Animals on the current study lost 12% (males) and 14% (females) of their initial
body weight over a four or six day period of food deprivation, respectively. Although it
is difficult to directly compare the males and females in our studies since the experiments
were performed in differing years, the rate of weight loss appeared to be very similar for
males and females and consistent with previous work (319). In keeping with past reports
in several species, food deprivation caused a significant decrease in total T4 and T3
(160;252-255). Circulating concentrations of total T4 appeared to be higher on day 0 in
males than in females and decreased more dramatically in males than females with food
deprivation. In contrast, circulating levels of total T4 increased in IGF-1 treated females,
reaching Day 0 levels in ewes treated with 10 ug/kg/d and exceeding Day 0 levels in
ewes treated with 50 ug/kg/d. Females also demonstrated a dramatic and dose-related
increase in total circulating T3 levels following IGF-1 treatment. In contrast, IGF-1
treated males were able to maintain total T4 levels until Day 2, after which circulating T4
dropped. Nonetheless, values in IGF-1 treated males remained above control values
suggesting that IGF-1 has the ability, albeit limited, to influence thyroid hormone levels
in food deprived males. Likewise, IGF-1 appeared to slow, in a dose-dependent fashion,
the decrease in T3 levels observed with fasting in males. Based on these data, we would
conclude that IGF-1 is a more potent stimulus of thyroid hormone levels in females than
in males.
The site of action at which IGF-1 stimulates thyroid hormone secretion as well as
the mechanism whereby this occurs is at present unknown. Very few studies have
addressed how IGF-1 or its secretagogue, GH, influence the HPT axis. Theoretically,
IGF-1 could influence thyroid hormone levels by acting at all levels of the HPT axis
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since IGF-1 receptor protein or mRNA has been localized to the hypothalamus and
pituitary (189), and the thyroid gland (492). To our knowledge, there is no data available
as to whether IGF-1 influences TRH release. A limited number of reports suggest that
GH or IGF-1 can inhibit pituitary TSH release (487;493-495). Klinger et al. (490)
showed that either a bolus i.v. or subcutaneous injection of IGF-1 reduced TSH levels
and proposed that this was due to increased somatostatin release. However, another
study by Trainer (496) observed decreased TSH levels after IGF-1 treatment without
significant changes in GH release and the author suggested that the suppression in TSH
was due to elevated T4 and T3. Our data are consistent with this explanation. A direct
action of IGF-1 at the pituitary is suggested by studies showing altered sensitivity to TRH
stimulation following GH or IGF-1 treatment (488;497;498). We did not measure TSH
in our study. TSH is difficult to detect in serum collected from thyroid-intact sheep (Dr.
Fred Karsch, personal communication), a fact confirmed by our attempt to measure TSH
with a commercially available assay. Further study will be needed to address the issue of
where IGF-1 acts to increase thyroid hormone levels.
In both females and males, circulating levels of total T3 appeared to follow closely
serum levels of total T4. This is not too surprising since at least 75% of all circulating T3
is derived from T4 by peripheral 5’-deiodination rather than from thyroid gland secretion
(257;499;500). The finding for females that total T3 levels increased prior to total T4
levels in our second experiment suggests that IGF-1 stimulates deiodinase activity. This
is consistent with previous work indicating that GH or IGF-1 treatment stimulates the
conversion of T4 to T3. Salamon et al. (501) observed that GH-deficient adults treated
with GH and who were on fixed doses of T4 replacement therapy developed

69

thyrotoxicosis associated with a rise in plasma T3 values. Grunfeld et al. (502) reported
that normal subjects treated with GH exhibited a decrease in TSH and T4, but increased
T3 levels. Other studies have also reported increased T3 but decreased T4 (487;488), or
increased T3 without a change in T4 (489;495) following hGH or IGF-1 administration.
Alternatively, increased T3 levels may have simply been due to increased precursor T4
levels without a change in deiodinase activity. Despite the fact that T3 levels increased
within 1 hour of IGF-1 administration, total T4 levels remained constant, suggesting that
T4 secretion likely was also being stimulated at this time.

Indeed, total T4 levels

increased significantly once total T3 levels reached their maximum. Thus, the IGF-1induced increase in total T3 levels observed for females in our study may result from an
increase in precursor T4 levels and/or an increase in deiodinase activity.
Most of the T3 and T4 that is transported in blood is bound to thyroid hormone
binding proteins (503;504). Since only the unbound, or free, hormones are able to enter
and affect cells, bound T3 and T4 is inactive until being released as free hormone into
plasma (505). Since we measured total T3 and T4 in circulation, we did not assess
whether free T3 or T4 changed with IGF-1 treatment. However, we would speculate that
our measurements of total T3 and T4 are of biological relevance for at least two reasons.
One is that in previous work examining the effect of GH or IGF-1 on thyroid hormone
release, the change in total hormone reflected that of free hormone (487;495;506). Two,
previous studies have shown no effect of GH administration on serum thyroglobulin
levels (487) or capacity (489).
As expected, insulin decreased following food deprivation. However, the change
in insulin appeared to be influenced by both gender and IGF-1 treatment. In control
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females, insulin levels decreased yet were clearly detectable on day 4 of food withdrawal
and did not change through Day 6. However, concentrations of insulin decreased to
assay sensitivity by Day 2 of food removal in control males. This is consistent with the
idea that males respond more robustly than females to food removal. On days 4 and 6 of
food removal, both IGF-10 and IGF-50 females exhibited lower circulating insulin
concentrations than control females. For IGF-50 females, this drop in insulin may be
related to an accompanying drop in blood glucose levels, perhaps due to the insulin-like
actions of IGF-1 (507;508). However, glucose levels in controls and IGF-10 females
were similar, suggesting that IGF-1 increased insulin sensitivity at this lower dose. This
is consistent with a previous study wherein IGF-1 decreased circulating insulin levels
although there was no change in glucose concentrations (494). In males, since insulin
levels dropped so quickly it was not possible to determine if IGF-1 had any effect on
insulin levels.
In summary, though body weight loss following food removal was relatively
similar between males and females, changes in circulating insulin, total T4, and total T3
were sex-dependent. Insulin, T4, and T3 levels decreased more quickly and to a greater
degree in food-deprived males than in food-deprived females. These results suggest that
males react more strongly to food deprivation and that females may be better able to deal,
in an energetic sense, with this type of perturbation in energy supply. Both sexes
demonstrated an increase in T3 and T4 over controls following IGF-1 treatment. Total T4
and T3 levels in females were increased to or beyond Day 0 control values after three
days of IGF-1 treatment. In contrast, during IGF-1 treatment, total T4 and T3 levels were
maintained in males for 2 days, after which they declined significantly. This response
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was observed even though males received similar or an even higher doses of IGF-1 as the
females. Based on these data, we would conclude that IGF-1 is a more potent stimulus of
thyroid hormone levels in females than in males. Further study is needed to determine
the mechanisms which underlie this sex-dependent response to IGF-1.
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Figure 1
A) Percent change from Day 0 body weight on Day 2 and Day 4 of food removal in
controls or wethers receiving IGF-1 subcutaneously twice daily at 25ug/kg/d, 50ug/kg/d,
or 100ug/kg/d beginning on Day 1. Weight loss increased over time (P<0.001), but did
not differ among the four groups (P>0.80). B) Percent change from Day 0 body weight
on Day 2, Day 4, and Day 6 of food removal in controls or ewes receiving IGF-1 at either
10ug/kg/d or 50ug/kg/d subcutaneously twice daily beginning on Day 3. Weight loss did
not differ (P>0.10) for the three groups.
Figure 2
Circulating levels of Total T3 and Total T4 during 6 days of food removal in controls or
ewes receiving IGF-1 subcutaneously twice daily at 10ug/kg/d or 50ug/kg/d beginning on
Day 3. A) Total T4 in control animals differed from IGF-1 treated groups on Day 2
(P<0.006) and Day 4 (P<0.007). Total T4 increased from Day 0 levels on Day 2 in
animals treated with 100ug/kg/d IGF-1 (P<0.05) and decreased in all groups on Day 4
when compared to Day 2. B) Total T3 levels in all groups did not differ significantly on
Days 0, 2, or 4 (P>0.05), but were significantly different from each other (P<0.05) on
Day 6.
Figure 3
Insulin and glucose levels during 6 days of food removal in controls or ewes receiving
IGF-1 at 10ug/kg/d or 50ug/kg/d subcutaneously twice daily beginning on Day 3. A)
Insulin levels in control ewes decreased from initial levels on Day 2 and remained
consistent at that level for the remainder of the treatment period. Insulin levels were not
significantly different between treated groups (P>0.05) but were lower (P<0.05) in IGF-1
treated groups compared to controls on Days 4 and 6 of fasting. B) Glucose did not
differ between 10ug/kg/d and control groups, and remained the same throughout the
treatment. Day 4 and 6 glucose values were lower than Day 0 and 2 values (P<0.05), and
were lower than either of the other groups on Days 4 and 6 (P<0.05).
Figure 4
Circulating levels of Total T3 and Total T4 during 4 days of food removal in controls or
wethers receiving IGF-1 at 25ug/kg/d, 50ug/kg/d, or 100ug/kg/d subcutaneously twice
daily beginning on Day 1. A) Total T4 decreased in control animals on each day of the
experiment. All treated groups maintained T4 at the same level between Days 0 and 2,
but decreased significantly on Day 4 (P<0.05). B) Total T3 levels decreased from Day 0
levels by Day 4 in control and 25ug/kg/d animals only (P<0.05). On Day 4 Total T3
levels in control animals differed from 50ug/kg/d and 100ug/kg/d (P<0.05). 25ug/kg/d
were also different from 100ug/kg/d treated groups (P<0.05). All groups decreased from
Day 0 values by Day 4.
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Figure 5
Insulin and glucose levels during 4 days of food removal in controls or wethers receiving
IGF-1 at 25ug/kg/d, 50ug/kg/d, or 100ug/kg/d subcutaneously twice daily beginning on
Day 1. A) Insulin levels decreased to undetectable levels in all groups by Day 2
(P<0.001). B) Glucose levels maintained in control animals throughout the experimental
period and decreased by for day0 values on Day 4 in all IGF-1 treated groups (P<0.05).
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